ヘルスケア分析市場 – 2029年までの世界予測

Report Overview

The global Healthcare analytics  market is projected to reach 133.19 billion by 2029 from 44.83 billion in 2024, at a CAGR of 24.3 % from 2024 to 2029.

世界のヘルスケア分析市場は、2024 年から 2029 年まで 24.3 % の CAGR で成長し、2024 年の 448 億 3000 万から 2029 年までに 1,331 億 9 千万に達すると予測されています。

The widespread adoption of Electronic Health Records (EHR) is accelerating the growth of the healthcare analytics market. In North America, approximately 78% of office-based physicians and 96% of non-federal acute care hospitals use EHR systems, which are supported by regulatory incentives such as the HITECH Act. Europe has varying adoption rates, with the Netherlands at 97% and an average of 81% across the continent, indicating a high potential for analytics integration. Increased adoption of EHRs improves data accessibility and drives the demand for advanced analytics solutions.

“Healthcare analytics , clinical analytics segment to witness the highest growth during the forecast period.”

Based on application,  the healthcare analytics  market is segmented into financial analytics, clinical analytics, operations & administrative analytics and population health analytics. The clinical analytics segment held the largest market share in 2023. Value-Based Care, technological advancements, and improved patient outcomes drive clinical analytics growth by focusing on outcome-based performance, optimizing costs, and enabling personalized, data-driven care through AI and EHR systems. This enhances care quality and efficiency, boosting the healthcare analytics market.

“APAC is estimated to register the highest CAGR during the forecast period.”

In this report, the healthcare analytics  market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East and Africa. The healthcare analytics market in APAC is projected to register the highest CAGR rate during the forecast period. The APAC healthcare analytics market is groqing due to affordable medical treatments, such as average cost of bypass surgery in APAC region is approximately  USD 4000, compared to USD 30,000 to USD 200,000 in the US. Moreover, government support for medical tourism, healthcare infrastructure investment, IT expansion, and a growing aging population with chronic diseases collectively strengthen the region’s position in global healthcare.

In-depth interviews have been conducted with chief executive officers (CEOs), Directors, and other executives from various key organizations operating in the authentication and brand protection marketplace.

• By Company Type: Tier 1 – 45%, Tier 2 – 35%, and Tier 20%
• By Designation: C-level Executives – 50%, Directors – 30%, and Others – 20%
• By Region: North America– 40%, Europe – 35%, Asia Pacific– 20% and RoW- 5%

Merative (US), Optum, Inc.(US), SAS Institute Inc. (US), Oracle (US), Citiustech Inc (US) are some of the key players in the healthcare analytics market.

The study includes an in-depth competitive analysis of these key players in the healthcare analytics market, with their company profiles, recent developments, and key market strategies.

Research Coverage

This research report categorizes the healthcare analytics market by component (Services, Software), by type (Descriptive analytics, Predictive analytics, Prescriptive analytics, Diagnostic analytics), by application (Financial analytics, Clinical analytics, Operations & Administration analytics, Population Health analytics), by end-user (Payers, Providers, Pharmaceutical & Medical device supply chain) and by region (North America, Europe, Asia Pacific, Latin America, and Middle East and Africa). The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, challenges, and opportunities, influencing the growth of the healthcare analytics market. A detailed analysis of the key industry players has been done to provide insights into their business overview, solutions, and services; key strategies; Contracts, partnerships, agreements. new product & service launches, mergers and acquisitions, and recent developments associated with the healthcare analytics market. Competitive analysis of upcoming startups in the healthcare analytics market ecosystem is covered in this report.

Reasons to buy this report

The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the healthcare analytics market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and to plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.

The report provides insights on the following pointers:

• Analysis of key drivers (Government initiatives to increase EHR adoption, Growing venture capital investments in healthcare analytics start-ups, Growing pressure to curb healthcare spending and improve patient outcomes, Heterogeneity and complexity of big data in healthcare, Growing focus on real-world evidence, Cost Management and Operational Efficiency, Rise of Telemedicine and Remote Monitoring, Regulatory Compliance and Quality Improvement, Increasing demand for data-driven decision-making), restraints (High cost of analytics solutions in healthcare organizations, Rising data breach concerns), opportunities (Increasing focus on value-based medicines, Use of analytics in precision and personalized medicines, Cloud-based analytics, Increasing number of patient registries, Emergence of social media and its impact on healthcare industry, Augmented analytics to supplement human intelligence, Analytics of healthcare things), and challenges (Concerns regarding inaccurate and inconsistent data, Reluctance to adopt healthcare analytics solutions in emerging countries, Data integration for coordinated care, Operational gaps between payers and providers, Dearth of skilled personnel) influencing the growth of the healthcare analytics market
• Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product & service launches in the healthcare analytics market
• Market Development: Comprehensive information about lucrative markets – the report analyses the healthcare analytics market across varied regions.
• Market Diversification: Exhaustive information about new products & services, untapped geographies, recent developments, and investments in the healthcare analytics market
• Competitive Assessment: In-depth assessment of market shares, growth strategies and service offerings of leading players like Merative (US), Optum, Inc.(US), SAS Institute Inc. (US), Oracle (US), Citiustech Inc (US), Inovalon (US), Mckesson Corporation (US), MedeAnalytics, Inc.(US), Cotiviti, Inc. (US), Exlservice Holdings, Inc. (US), Wipro (India), Apixio. (US); among others in healthcare analytics market

Table of Contents

1            INTRODUCTION            38

1.1         STUDY OBJECTIVES      38

1.2         MARKET DEFINITION   38

1.3         STUDY SCOPE  39

1.3.1      MARKETS COVERED AND REGIONAL SCOPE     39

1.3.2      INCLUSIONS AND EXCLUSIONS 40

1.3.3      YEARS CONSIDERED     40

1.4         CURRENCY CONSIDERED          40

1.5         STAKEHOLDERS            41

1.6         SUMMARY OF CHANGES            41

1.7         IMPACT OF AI/GEN AI  41

2            RESEARCH METHODOLOGY     42

2.1         RESEARCH APPROACH 42

2.1.1      SECONDARY DATA       43

2.1.1.1   Key data from secondary sources     44

2.1.2      PRIMARY DATA 44

2.1.2.1   Key data from primary sources         45

2.1.2.2   Insights from primary experts          46

2.2         RESEARCH METHODOLOGY DESIGN    47

2.3         MARKET SIZE ESTIMATION METHODOLOGY    48

2.4         MARKET BREAKDOWN AND DATA TRIANGULATION    54

2.5         RESEARCH ASSUMPTIONS         55

2.6         RESEARCH LIMITATIONS           55

2.6.1      METHODOLOGY-RELATED LIMITATIONS         55

2.6.2      SCOPE-RELATED LIMITATIONS             56

2.7         RISK ASSESSMENT         56

3            EXECUTIVE SUMMARY 57

4            PREMIUM INSIGHTS      61

4.1         HEALTHCARE ANALYTICS MARKET OVERVIEW 61

4.2         NORTH AMERICA: HEALTHCARE ANALYTICS MARKET SHARE, BY END USER AND COUNTRY (2023)      62

4.3         HEALTHCARE ANALYTICS MARKET, BY COUNTRY         63

4.4         HEALTHCARE ANALYTICS MARKET: REGIONAL MIX      63

4.5         HEALTHCARE ANALYTICS MARKET: EMERGING ECONOMIES VS. DEVELOPED COUNTRIES          64

5            MARKET OVERVIEW     65

5.1         INTRODUCTION            65

5.2         MARKET DYNAMICS     65

5.2.1      DRIVERS            66

5.2.1.1   Favorable government initiatives for electronic health record adoption    66

5.2.1.2   Growing venture capital investments in startups          67

5.2.1.3   Need to reduce healthcare costs       67

5.2.1.4   Increasing focus on real-world evidence         68

5.2.1.5   Rise of telemedicine and remote patient monitoring    69

5.2.1.6   Growing focus on regulatory compliance       69

5.2.2      RESTRAINTS     70

5.2.2.1   High cost of analytics solutions        70

5.2.2.2   Growing concerns about data breach             70

5.2.3      OPPORTUNITIES           73

5.2.3.1   Increasing focus on value-based medicines    73

5.2.3.2   Growing use of analytics in healthcare           74

5.2.3.3   Rising number of patient registries   75

5.2.3.4   Emergence of social media and digital health technologies         75

5.2.4      CHALLENGES   75

5.2.4.1   Concerns regarding inaccurate and inconsistent data   75

5.2.4.2   Reluctance to adopt healthcare analytics solutions in developing countries              76

5.2.4.3   Lack of maintenance of medical records         76

5.2.4.4   Shortage of skilled personnel           76

5.3         TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS       77

5.4         INDUSTRY TRENDS       78

5.4.1      INCREASING PARTNERSHIPS AND COLLABORATIONS AMONG MARKET PLAYERS         78

5.4.2      SHIFT OF RISK BURDEN FROM PAYERS TO PROVIDERS 78

5.4.3      GROWING ADOPTION OF CLOUD-BASED IT SOLUTIONS           79

5.5         ECOSYSTEM ANALYSIS 80

5.6         VALUE CHAIN ANALYSIS            82

5.7         TECHNOLOGY ANALYSIS           83

5.7.1      KEY TECHNOLOGIES    83

5.7.1.1   Big data analytics 83

5.7.1.2   Artificial intelligence and machine learning    84

5.7.1.3   Business intelligence tools 84

5.7.2      ADJACENT TECHNOLOGIES      85

5.7.2.1   Cloud computing 85

5.7.2.2   Internet of things 85

5.8         REGULATORY LANDSCAPE       86

5.8.1      REGULATORY ANALYSIS            86

5.8.2      GOVERNMENT REGULATIONS 89

5.8.2.1   US         89

5.8.2.2   Europe  89

5.8.2.3   China     89

5.8.2.4   Japan     89

5.8.2.5   India      90

5.8.3      REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS          90

5.9         PRICING ANALYSIS        92

5.9.1      AVERAGE SELLING PRICE OF HEALTHCARE ANALYTICS SOLUTIONS, BY COMPONENT           93

5.9.2      AVERAGE SELLING PRICE, BY REGION  93

5.10       PORTER’S FIVE FORCES ANALYSIS         94

5.11       PATENT ANALYSIS        97

5.12       KEY STAKEHOLDERS AND BUYING CRITERIA    99

5.12.1    KEY STAKEHOLDERS IN BUYING PROCESS         99

5.12.2    BUYING CRITERIA         100

5.13       END-USER ANALYSIS    101

5.13.1    UNMET NEEDS 101

5.13.2    END-USER EXPECTATIONS       102

5.14       KEY CONFERENCES AND EVENTS, 2024–2025     103

5.15       CASE STUDY ANALYSIS 104

5.16       BUSINESS MODEL ANALYSIS     107

5.17       INVESTMENT AND FUNDING SCENARIO            108

5.18       IMPACT OF AI/GEN AI ON HEALTHCARE ANALYTICS MARKET 109

5.18.1    KEY USE CASES 110

5.18.2    CASE STUDY ON AI/GEN AI        110

5.18.3    ADJACENT MARKET ECOSYSTEM           111

5.18.3.1 Life science analytics market            111

5.18.3.2 Healthcare IT market         112

5.18.3.3 Healthcare fraud analytics market    112

5.18.4    USER READINESS AND IMPACT ASSESSMENT    112

5.18.4.1 User readiness     112

5.18.4.1.1            Payers   112

5.18.4.1.2            Providers             112

5.18.4.2 Impact assessment             113

5.18.4.2.1            User A: Payers     113

5.18.4.2.1.1         Implementation   113

5.18.4.2.1.2         Impact   113

5.18.4.2.2            User B: Providers 113

5.18.4.2.2.1         Implementation   113

5.18.4.2.2.2         Impact   114

6            HEALTHCARE ANALYTICS MARKET, BY COMPONENT  115

6.1         INTRODUCTION            116

6.2         SERVICES          116

6.2.1      MANAGED SERVICES    118

6.2.1.1   Analytical services             120

6.2.1.1.1 Increasing volume of healthcare data to facilitate growth            120

6.2.1.2   Consulting services            121

6.2.1.2.1 Need to improve clinical outcomes and patient satisfaction to support growth              121

6.2.2      PROFESSIONAL SERVICES          122

6.2.2.1   Training & implementation services 124

6.2.2.1.1 Growing emphasis on value-based care and specialized training services to drive market   124

6.2.2.2   Maintenance & support services       125

6.2.2.2.1 Expanding research needs to propel demand for maintenance & support services              125

6.3         SOFTWARE       126

6.3.1      ON-PREMISE SOFTWARE           128

6.3.1.1   Provision of multi-vendor architecture and security benefits to drive market              128

6.3.2      CLOUD-BASED SOFTWARE       130

6.3.2.1   Real-time analysis and elimination of purchasing costs for software & hardware to drive adoption     130

7            HEALTHCARE ANALYTICS MARKET, BY TYPE    132

7.1         INTRODUCTION            133

7.2         DESCRIPTIVE ANALYTICS          133

7.2.1      INCREASING USE IN PATIENT POPULATION MANAGEMENT AND FINANCIAL MANAGEMENT TO BOOST MARKET             133

7.3         PREDICTIVE ANALYTICS            135

7.3.1      ABILITY OF PREDICTIVE ANALYTICS TO HELP HEALTHCARE ORGANIZATIONS AVOID PREVENTABLE EVENTS TO SUPPORT GROWTH              135

7.4         PRESCRIPTIVE ANALYTICS        137

7.4.1      NEED FOR BETTER TREATMENT METHODS AND BUSINESS PRACTICES TO ENCOURAGE GROWTH 137

7.5         DIAGNOSTIC ANALYTICS          139

7.5.1      RISE IN LAUNCHES OF AI-DRIVEN ANALYTICS PRODUCTS AND SERVICES TO EXPEDITE GROWTH         139

8            HEALTHCARE ANALYTICS MARKET, BY APPLICATION  141

8.1         INTRODUCTION            142

8.2         FINANCIAL ANALYTICS 142

8.2.1      CLAIMS PROCESSING   144

8.2.1.1   Increasing shift from paper-based claims processing to electronic mode to augment growth   144

8.2.2      REVENUE CYCLE MANAGEMENT           146

8.2.2.1   Growing focus on financial forecasting and budgeting process to boost market              146

8.2.3      PAYMENT INTEGRITY & FRAUD, WASTE, AND ABUSE    147

8.2.3.1   Implementation of ICD-10 code sets and adoption of fee-for-value systems to drive market        147

8.2.4      RISK ADJUSTMENT & ASSESSMENT       149

8.2.4.1   Rise in special enrollment periods and new subsidies to accelerate growth              149

8.3         CLINICAL ANALYTICS  151

8.3.1      QUALITY IMPROVEMENT & CLINICAL BENCHMARKING             153

8.3.1.1   Growing adoption of benchmarking to identify negative issues impacting healthcare systems to drive market   153

8.3.2      CLINICAL DECISION SUPPORT 154

8.3.2.1   Need to reduce medical errors and expedite diagnosis to boost market     154

8.3.3      REPORTING & COMPLIANCE    156

8.3.3.1   Ability to track regulatory changes, assess non-compliance, and perform internal audits to sustain growth     156

8.3.4      COMPARATIVE ANALYTICS/EFFECTIVENESS    157

8.3.4.1   Growing adoption of electronic health records to fuel market     157

8.3.5      PRECISION HEALTH/REAL-WORLD EVIDENCE 158

8.3.5.1   Strong government support for personalized medicine to sustain growth 158

8.3.6      MEDICAL IMAGING ANALYTICS             160

8.3.6.1   Ability to provide real-time insights and diagnosis of genetic disorders to aid growth   160

8.4         OPERATIONAL & ADMINISTRATIVE ANALYTICS             161

8.4.1      SUPPLY CHAIN ANALYTICS       163

8.4.1.1   Growing need to reduce healthcare costs and implement better inventory management practices to fuel market             163

8.4.2      WORKFORCE ANALYTICS          165

8.4.2.1   Need for effective recruitment to favor growth             165

8.4.3      STRATEGIC ANALYTICS             166

8.4.3.1   Growing use of advanced analytics tools for geographic expansion and service line expansion to drive market  166

8.5         POPULATION HEALTH ANALYTICS       167

8.5.1      RISING USE IN CLINICAL OUTCOME ENGAGEMENT AND POPULATION RISK MANAGEMENT TO SPUR GROWTH            167

9            HEALTHCARE ANALYTICS MARKET, BY END USER         169

9.1         INTRODUCTION            170

9.2         PAYERS 170

9.2.1      PRIVATE INSURANCE COMPANIES         172

9.2.1.1   Increasing reliance on analytics for fraud prevention and claims processing to contribute to growth          172

9.2.2      GOVERNMENT AGENCIES         173

9.2.2.1   Rising use of analytics solutions to maximize payment accuracy and set reimbursement rates to boost market             173

9.3         PROVIDERS       174

9.3.1      HOSPITALS & CLINICS  176

9.3.1.1   Growing adoption of healthcare analytics solutions by large hospitals, medical groups, and physician practices to boost market           176

9.3.2      POST-ACUTE CARE ORGANIZATIONS   177

9.3.2.1   Increasing use of analytics solutions to review and study patient data to drive market   177

9.3.3      AMBULATORY SURGERY CENTERS        178

9.3.3.1   Need to control healthcare costs to support market      178

9.3.4      OTHER PROVIDERS       180

9.4         PHARMACEUTICAL & MEDICAL DEVICE SUPPLY CHAIN             182

9.4.1      MANUFACTURERS        183

9.4.1.1   Growing adoption of digital technologies to drive market           183

9.4.2      DISTRIBUTORS & WHOLESALERS           185

9.4.2.1   Need for improved supply chain operations, inventory management, and service delivery to boost market     185

9.4.3      RETAILERS        186

9.4.3.1   Rising integration of healthcare analytics into retail operations to stimulate growth              186

10          HEALTHCARE ANALYTICS MARKET, BY REGION             187

10.1       INTRODUCTION            188

10.2       NORTH AMERICA          189

10.2.1    MACROECONOMIC OUTLOOK FOR NORTH AMERICA   189

10.2.2    US         196

10.2.2.1 High adoption of electronic health records to drive market         196

10.2.3    CANADA            202

10.2.3.1 Need for managing patient volumes, clinical data, and healthcare costs to favor market   202

10.3       EUROPE             208

10.3.1    MACROECONOMIC OUTLOOK FOR EUROPE     208

10.3.2    GERMANY         214

10.3.2.1 Government initiatives to increase use of analytics in healthcare 214

10.3.3    UK         220

10.3.3.1 Availability of venture capital investments to drive market         220

10.3.4    FRANCE             225

10.3.4.1 Strong financial support for digital health to augment market    225

10.3.5    ITALY   231

10.3.5.1 Growing number of drug approvals to drive uptake of analytics solutions 231

10.3.6    SPAIN   236

10.3.6.1 Growing adoption of personalized medicine to drive market      236

10.3.7    REST OF EUROPE           241

10.4       ASIA PACIFIC    246

10.4.1    MACROECONOMIC OUTLOOK FOR ASIA PACIFIC          247

10.4.2    JAPAN  254

10.4.2.1 Rising geriatric population to drive demand for effective patient management solutions 254

10.4.3    CHINA  259

10.4.3.1 Favorable reforms and growing number of electronic health records to aid growth              259

10.4.4    INDIA   264

10.4.4.1 Favorable government initiatives to fuel market           264

10.4.5    REST OF ASIA PACIFIC  270

10.5       LATIN AMERICA             275

10.5.1    MACROECONOMIC OUTLOOK FOR LATIN AMERICA     276

10.5.2    BRAZIL 282

10.5.2.1 Growing adoption of digital solutions in healthcare to boost market         282

10.5.3    MEXICO             288

10.5.3.1 Growing prominence of startups and rising R&D activity to propel market              288

10.5.4    REST OF LATIN AMERICA          293

10.6       MIDDLE EAST & AFRICA             298

10.6.1    MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA     299

10.6.2    GCC COUNTRIES           305

10.6.2.1 Rising investments, advancements, and developing healthcare infrastructure to drive market        305

10.6.3    REST OF MIDDLE EAST & AFRICA           311

11          COMPETITIVE LANDSCAPE       317

11.1       INTRODUCTION            317

11.2       KEY PLAYER STRATEGIES/RIGHT TO WIN, 2021–2024     317

11.3       REVENUE ANALYSIS, 2019–2023 319

11.4       MARKET SHARE ANALYSIS, 2023             320

11.5       COMPANY EVALUATION AND FINANCIAL METRICS      322

11.6       BRAND/SOFTWARE COMPARISON         323

11.7       COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023   324

11.7.1    STARS  324

11.7.2    EMERGING LEADERS    324

11.7.3    PERVASIVE PLAYERS     324

11.7.4    PARTICIPANTS 324

11.7.5    COMPANY FOOTPRINT: KEY PLAYERS, 2023      326

11.7.5.1 Company footprint            326

11.7.5.2 Region footprint  327

11.7.5.3 Component footprint         328

11.7.5.4 Application footprint         329

11.7.5.5 End-user footprint             330

11.8       COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023          331

11.8.1    PROGRESSIVE COMPANIES       331

11.8.2    RESPONSIVE COMPANIES          331

11.8.3    DYNAMIC COMPANIES 331

11.8.4    STARTING BLOCKS       331

11.8.5    COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023             333

11.8.5.1 Detailed list of key startups/SMEs   333

11.8.5.2 Competitive benchmarking of key startups/SMEs        334

11.9       COMPETITIVE SCENARIO          335

11.9.1    PRODUCT/SOLUTION LAUNCHES/ENHANCEMENTS/APPROVALS/ UPGRADES       335

11.9.2    DEALS  336

11.9.3    EXPANSIONS    337

12          COMPANY PROFILES    338

12.1       KEY PLAYERS   338

12.1.1    MERATIVE        338

12.1.1.1 Business overview 338

12.1.1.2 Products/Solutions/Services offered 339

12.1.1.3 Recent developments         339

12.1.1.3.1            Product/Solution Launches/Enhancements/Approvals/ Upgrades              339

12.1.1.3.2            Deals     340

12.1.1.4 MnM view           340

12.1.1.4.1            Key strengths       340

12.1.1.4.2            Strategic choices  340

12.1.1.4.3            Weaknesses and competitive threats 340

12.1.2    SAS INSTITUTE INC.      341

12.1.2.1 Business overview 341

12.1.2.2 Products/Solutions/Services offered 341

12.1.2.3 Recent developments         342

12.1.2.3.1            Product/Solution Launches/Enhancements/Approvals/ Upgrades              342

12.1.2.4 MnM view           343

12.1.2.4.1            Key strengths       343

12.1.2.4.2            Strategic choices  343

12.1.2.4.3            Weaknesses and competitive threats 343

12.1.3    OPTUM, INC.     344

12.1.3.1 Business overview 344

12.1.3.2 Products/Solutions/Services offered 345

12.1.3.3 Recent developments         346

12.1.3.3.1            Deals     346

12.1.3.4 MnM view           347

12.1.3.4.1            Key strengths       347

12.1.3.4.2            Strategic choices  347

12.1.3.4.3            Weaknesses and competitive threats 347

12.1.4    ORACLE             348

12.1.4.1 Business overview 348

12.1.4.2 Products/Solutions/Services offered 349

12.1.4.3 Recent developments         350

12.1.4.3.1            Product/Solution Launches/Enhancements/Approvals/ Upgrades              350

12.1.4.3.2            Deals     351

12.1.4.3.3            Expansions          352

12.1.4.4 MnM view           352

12.1.4.4.1            Key strengths       352

12.1.4.4.2            Strategic choices  352

12.1.4.4.3            Weaknesses and competitive threats 352

12.1.5    VERADIGM LLC 353

12.1.5.1 Business overview 353

12.1.5.2 Products/Solutions/Services offered 354

12.1.5.3 Recent developments         355

12.1.5.3.1            Product/Solution Launches/Enhancements/Approvals/ Upgrades              355

12.1.5.3.2            Deals     355

12.1.5.3.3            Expansions          357

12.1.5.3.4            Other developments          357

12.1.5.4 MnM view           357

12.1.5.4.1            Key strengths       357

12.1.5.4.2            Strategic choices  357

12.1.5.4.3            Weaknesses and competitive threats 358

12.1.6    EXLSERVICE HOLDINGS, INC.   359

12.1.6.1 Business overview 359

12.1.6.2 Products/Solutions/Services offered 360

12.1.6.3 Recent developments         361

12.1.6.3.1            Product/Solution Launches/Enhancements/Approvals/ Upgrades              361

12.1.6.3.2            Deals     361

12.1.6.3.3            Other developments          362

12.1.7    CITIUSTECH INC.           363

12.1.7.1 Business overview 363

12.1.7.2 Products/Solutions/Services offered 363

12.1.7.3 Recent developments         364

12.1.7.3.1            Product/Solution Launches/Enhancements/Approvals/ Upgrades              364

12.1.7.3.2            Deals     365

12.1.7.3.3            Expansions          365

12.1.7.3.4            Other developments          365

12.1.8    HEALTH CATALYST      366

12.1.8.1 Business overview 366

12.1.8.2 Products/Solutions/Services offered 367

12.1.8.3 Recent developments         368

12.1.8.3.1            Product/Solution Launches/Enhancements/Approvals/ Upgrades              368

12.1.8.3.2            Deals     368

12.1.9    CVS HEALTH    370

12.1.9.1 Business overview 370

12.1.9.2 Products/Solutions/Services offered 371

12.1.9.3 Recent developments         372

12.1.9.3.1            Deals     372

12.1.10  INOVALON        373

12.1.10.1             Business overview 373

12.1.10.2             Products/Solutions/Services offered 373

12.1.10.3             Recent developments         374

12.1.10.3.1          Product/Solution Launches/Enhancements/Approvals/ Upgrades              374

12.1.10.3.2          Deals     375

12.1.10.3.3          Expansions          375

12.1.10.3.4          Other developments          375

12.1.11  MCKESSON CORPORATION       376

12.1.11.1             Business overview 376

12.1.11.2             Products/Solutions/Services offered 377

12.1.11.3             Recent developments         378

12.1.11.3.1          Deals     378

12.1.12  MEDEANALYTICS, INC. 379

12.1.12.1             Business overview 379

12.1.12.2             Products/Solutions/Services offered 379

12.1.12.3             Recent developments         380

12.1.12.3.1          Deals     380

12.1.12.3.2          Other developments          380

12.1.13  COTIVITI, INC.  381

12.1.13.1             Business overview 381

12.1.13.2             Products/Solutions/Services offered 381

12.1.13.3             Recent developments         382

12.1.13.3.1          Product/Solution Launches/Enhancements/Approvals/ Upgrades              382

12.1.13.3.2          Other developments          382

12.1.14  APIXIO, INC.      383

12.1.14.1             Business overview 383

12.1.14.2             Products/Solutions/Services offered 383

12.1.14.3             Recent developments         384

12.1.14.3.1          Product/Solution Launches/Enhancements/Approvals/ Upgrades              384

12.1.14.3.2          Deals     385

12.1.15  ENLITIC             386

12.1.15.1             Business overview 386

12.1.15.2             Products/Solutions/Services offered 386

12.1.15.3             Recent developments         387

12.1.15.3.1          Product/Solution Launches/Enhancements/Approvals/ Upgrades              387

12.1.15.3.2          Deals     388

12.1.16  KOMODO HEALTH, INC.            389

12.1.16.1             Business overview 389

12.1.16.2             Products/Solutions/Services offered 389

12.1.16.3             Recent developments         390

12.1.16.3.1          Product/Solution Launches/Enhancements/Approvals/ Upgrades              390

12.1.16.3.2          Deals     390

12.1.17  HEALTHEC, LLC            392

12.1.17.1             Business overview 392

12.1.17.2             Products/Solutions/Services offered 392

12.1.17.3             Recent developments         392

12.1.17.3.1          Deals     392

12.1.18  IQVIA   393

12.1.18.1             Business overview 393

12.1.18.2             Products/Solutions/Services offered 394

12.1.18.3             Recent developments         395

12.1.18.3.1          Deals     395

12.1.19  WIPRO 396

12.1.19.1             Business overview 396

12.1.19.2             Products/Solutions/Services offered 398

12.2       OTHER PLAYERS           399

12.2.1    ARCADIA SOLUTIONS, LLC.       399

12.2.2    EVIDATION HEALTH, INC.         399

12.2.3    HEALTHCORUM            400

12.2.4    AETION, INC.    400

12.2.5    TREDENCE.INC.             401

12.2.6    SISENSE LTD.    401

13          APPENDIX         402

13.1       DISCUSSION GUIDE      402

13.2       KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL             407

13.3       CUSTOMIZATION OPTIONS      409

13.4       RELATED REPORTS       409

13.5       AUTHOR DETAILS         410

LIST OF TABLES

TABLE 1             HEALTHCARE ANALYTICS MARKET: INCLUSIONS AND EXCLUSIONS    40

TABLE 2             HEALTHCARE ANALYTICS MARKET: RESEARCH ASSUMPTIONS              55

TABLE 3             HEALTHCARE ANALYTICS MARKET: RISK ASSESSMENT 56

TABLE 4             HEALTHCARE DATA BREACHES: ENTITIES, IMPACT, AND CAUSES, 2023    73

TABLE 5             HEALTHCARE ANALYTICS MARKET: ROLE OF COMPANIES IN ECOSYSTEM     80

TABLE 6             NORTH AMERICA: REGULATIONS GOVERNING HEALTHCARE ANALYTICS MARKET    86

TABLE 7             EUROPE: REGULATIONS GOVERNING HEALTHCARE ANALYTICS MARKET    87

TABLE 8             ASIA PACIFIC: REGULATIONS GOVERNING HEALTHCARE ANALYTICS MARKET    87

TABLE 9             MIDDLE EAST & AFRICA: REGULATIONS GOVERNING HEALTHCARE ANALYTICS MARKET      88

TABLE 10           LATIN AMERICA: REGULATIONS GOVERNING HEALTHCARE ANALYTICS MARKET    89

TABLE 11           NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS         90

TABLE 12           EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 90

TABLE 13           ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS         91

TABLE 14           LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS         92

TABLE 15           MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS         92

TABLE 16           AVERAGE SELLING PRICE OF HEALTHCARE ANALYTICS SOLUTIONS,

BY COMPONENT           93

TABLE 17           AVERAGE SELLING PRICE OF ANALYTICS SOLUTIONS, BY REGION             94

TABLE 18           HEALTHCARE ANALYTICS MARKET: PORTER’S FIVE FORCES ANALYSIS          95

TABLE 19           HEALTHCARE ANALYTICS MARKET: INNOVATIONS AND PATENT REGISTRATIONS, 2020–2023     98

TABLE 20           INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR END USER (%)  100

TABLE 21           KEY BUYING CRITERIA FOR END USER  100

TABLE 22           UNMET NEEDS IN HEALTHCARE ANALYTICS MARKET  101

TABLE 23           END-USER EXPECTATIONS IN HEALTHCARE ANALYTICS MARKET            102

TABLE 24           HEALTHCARE ANALYTICS MARKET: KEY CONFERENCES AND EVENTS, 2024–2025        103

TABLE 25           ADOPTION OF HEALTH CATALYST DATA OPERATING SYSTEM FOR IMPROVED ANNUAL SAVINGS        104

TABLE 26           USE OF COMPREHENSIVE DATA ANALYTICS PLATFORM TO MEET NEEDS OF EVOLVING HEALTHCARE ENVIRONMENT       105

TABLE 27           ENHANCED CLINICAL DECISION-MAKING PROCESS WITH DATA OPERATING SYSTEM PLATFORM 106

TABLE 28           ENHANCED PATIENT OUTCOMES WITH AI-DRIVEN PREDICTIVE ANALYTICS            110

TABLE 29           HEALTHCARE ANALYTICS MARKET, BY COMPONENT, 2022–2029 (USD MILLION)     116

TABLE 30           HEALTHCARE ANALYTICS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)     117

TABLE 31           HEALTHCARE ANALYTICS SERVICES MARKET, BY REGION,

2022–2029 (USD MILLION)          118

TABLE 32           HEALTHCARE ANALYTICS MARKET FOR MANAGED SERVICES, BY TYPE,

2022–2029 (USD MILLION)          119

TABLE 33           HEALTHCARE ANALYTICS MARKET FOR MANAGED SERVICES, BY REGION,

2022–2029 (USD MILLION)          119

TABLE 34           HEALTHCARE ANALYTICS MARKET FOR ANALYTICAL SERVICES, BY REGION,

2022–2029 (USD MILLION)          121

TABLE 35           HEALTHCARE ANALYTICS MARKET FOR CONSULTING SERVICES, BY REGION, 2022–2029 (USD MILLION)           122

TABLE 36           HEALTHCARE ANALYTICS MARKET FOR PROFESSIONAL SERVICES, BY TYPE,

2022–2029 (USD MILLION)          123

TABLE 37           HEALTHCARE ANALYTICS MARKET FOR PROFESSIONAL SERVICES, BY REGION, 2022–2029 (USD MILLION)           124

TABLE 38           HEALTHCARE ANALYTICS MARKET FOR TRAINING & IMPLEMENTATION SERVICES, BY REGION, 2022–2029 (USD MILLION)   125

TABLE 39           HEALTHCARE ANALYTICS MARKET FOR MAINTENANCE & SUPPORT SERVICES,

BY REGION, 2022–2029 (USD MILLION)  126

TABLE 40           HEALTHCARE ANALYTICS SOFTWARE MARKET, BY TYPE,

2022–2029 (USD MILLION)          127

TABLE 41           HEALTHCARE ANALYTICS SOFTWARE MARKET, BY REGION,

2022–2029 (USD MILLION)          128

TABLE 42           HEALTHCARE ANALYTICS MARKET FOR ON-PREMISE SOFTWARE, BY REGION, 2022–2029 (USD MILLION)        129

TABLE 43           HEALTHCARE ANALYTICS MARKET FOR CLOUD-BASED SOFTWARE, BY REGION, 2022–2029 (USD MILLION)        131

TABLE 44           HEALTHCARE ANALYTICS MARKET, BY TYPE, 2022–2029 (USD MILLION)          133

TABLE 45           DESCRIPTIVE ANALYTICS MARKET, BY REGION, 2022–2029 (USD MILLION) 134

TABLE 46           APPLICATIONS OF PREDICTIVE ANALYTICS      135

TABLE 47           COMMERCIALLY AVAILABLE PREDICTIVE ANALYTICS SOLUTIONS      136

TABLE 48           PREDICTIVE ANALYTICS MARKET, BY REGION, 2022–2029 (USD MILLION)          137

TABLE 49           COMMERCIALLY AVAILABLE PRESCRIPTIVE ANALYTICS SOLUTIONS      138

TABLE 50           PRESCRIPTIVE ANALYTICS MARKET, BY REGION, 2022–2029 (USD MILLION) 138

TABLE 51           DIAGNOSTIC ANALYTICS MARKET, BY REGION, 2022–2029 (USD MILLION) 140

TABLE 52           HEALTHCARE ANALYTICS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)     142

TABLE 53           COMMERCIALLY AVAILABLE FINANCIAL ANALYTICS SOLUTIONS      143

TABLE 54           FINANCIAL ANALYTICS MARKET, BY TYPE, 2022–2029 (USD MILLION)          143

TABLE 55           FINANCIAL ANALYTICS MARKET, BY REGION, 2022–2029 (USD MILLION)          144

TABLE 56           COMMERCIALLY AVAILABLE CLAIMS PROCESSING SOLUTIONS      145

TABLE 57           FINANCIAL ANALYTICS MARKET FOR CLAIMS PROCESSING, BY REGION,

2022–2029 (USD MILLION)          145

TABLE 58           COMMERCIALLY AVAILABLE REVENUE CYCLE MANAGEMENT SOLUTIONS      146

TABLE 59           FINANCIAL ANALYTICS MARKET FOR REVENUE CYCLE MANAGEMENT, BY REGION, 2022–2029 (USD MILLION) 147

TABLE 60           COMMERCIALLY AVAILABLE PAYMENT INTEGRITY & FWA SOLUTIONS      148

TABLE 61           FINANCIAL ANALYTICS MARKET FOR PAYMENT INTEGRITY & FWA, BY REGION, 2022–2029 (USD MILLION)      149

TABLE 62           COMMERCIALLY AVAILABLE RISK ADJUSTMENT & ASSESSMENT SOLUTIONS         150

TABLE 63           FINANCIAL ANALYTICS MARKET FOR RISK ADJUSTMENT & ASSESSMENT,

BY REGION, 2022–2029 (USD MILLION)  150

TABLE 64           COMMERCIALLY AVAILABLE CLINICAL ANALYTICS SOLUTIONS      151

TABLE 65           CLINICAL ANALYTICS MARKET, BY TYPE, 2022–2029 (USD MILLION)          152

TABLE 66           CLINICAL ANALYTICS MARKET, BY REGION, 2022–2029 (USD MILLION)          152

TABLE 67           COMMERCIALLY AVAILABLE QUALITY IMPROVEMENT & CLINICAL

BENCHMARKING SOLUTIONS  153

TABLE 68           CLINICAL ANALYTICS MARKET FOR QUALITY IMPROVEMENT & CLINICAL BENCHMARKING, BY REGION, 2022–2029 (USD MILLION)    154

TABLE 69           COMMERCIALLY AVAILABLE SOLUTIONS FOR CLINICAL DECISION SUPPORT      155

TABLE 70           CLINICAL ANALYTICS MARKET FOR CLINICAL DECISION SUPPORT, BY REGION, 2022–2029 (USD MILLION)           155

TABLE 71           COMMERCIALLY AVAILABLE SOLUTIONS FOR REPORTING & COMPLIANCE   156

TABLE 72           CLINICAL ANALYTICS MARKET FOR REPORTING & COMPLIANCE, BY REGION, 2022–2029 (USD MILLION)   157

TABLE 73           COMMERCIALLY AVAILABLE SOLUTIONS FOR COMPARATIVE ANALYTICS/EFFECTIVENESS    157

TABLE 74           CLINICAL ANALYTICS MARKET FOR COMPARATIVE ANALYTICS/EFFECTIVENESS,

BY REGION, 2022–2029 (USD MILLION)  158

TABLE 75           COMMERCIALLY AVAILABLE PRECISION HEALTH/REAL-WORLD EVIDENCE SOLUTIONS             159

TABLE 76           CLINICAL ANALYTICS MARKET FOR PRECISION HEALTH/REAL-WORLD EVIDENCE, BY REGION, 2022–2029 (USD MILLION)              159

TABLE 77           COMMERCIALLY AVAILABLE SOLUTIONS FOR MEDICAL IMAGING ANALYTICS   160

TABLE 78           CLINICAL ANALYTICS MARKET FOR MEDICAL IMAGING ANALYTICS, BY REGION, 2022–2029 (USD MILLION)       161

TABLE 79           COMMERCIALLY AVAILABLE SOLUTIONS FOR OPERATIONAL & ADMINISTRATIVE ANALYTICS            162

TABLE 80           OPERATIONAL & ADMINISTRATIVE ANALYTICS MARKET, BY TYPE,

2022–2029 (USD MILLION)          162

TABLE 81           OPERATIONAL & ADMINISTRATIVE ANALYTICS MARKET, BY REGION,

2022–2029 (USD MILLION)          163

TABLE 82           COMMERCIALLY AVAILABLE SUPPLY CHAIN ANALYTICS SOLUTIONS      164

TABLE 83           OPERATIONAL & ADMINISTRATIVE ANALYTICS MARKET FOR SUPPLY CHAIN ANALYTICS, BY REGION, 2022–2029 (USD MILLION)        164

TABLE 84           COMMERCIALLY AVAILABLE WORKFORCE ANALYTICS SOLUTIONS      165

TABLE 85           OPERATIONAL & ADMINISTRATIVE ANALYTICS MARKET FOR WORKFORCE ANALYTICS, BY REGION, 2022–2029 (USD MILLION)           166

TABLE 86           OPERATIONAL & ADMINISTRATIVE ANALYTICS MARKET FOR STRATEGIC ANALYTICS, BY REGION, 2022–2029 (USD MILLION) 167

TABLE 87           COMMERCIALLY AVAILABLE POPULATION HEALTH ANALYTICS SOLUTIONS            168

TABLE 88           POPULATION HEALTH ANALYTICS MARKET, BY REGION,

2022–2029 (USD MILLION)          168

TABLE 89           HEALTHCARE ANALYTICS MARKET, BY END USER, 2022–2029 (USD MILLION) 170

TABLE 90           COMMERCIALLY AVAILABLE SOLUTIONS FOR HEALTHCARE PAYERS 170

TABLE 91           HEALTHCARE ANALYTICS MARKET FOR PAYERS, BY TYPE,

2022–2029 (USD MILLION)          171

TABLE 92           HEALTHCARE ANALYTICS MARKET FOR PAYERS, BY REGION,

2022–2029 (USD MILLION)          171

TABLE 93           HEALTHCARE ANALYTICS MARKET FOR PRIVATE INSURANCE COMPANIES,

BY REGION, 2022–2029 (USD MILLION)  172

TABLE 94           HEALTHCARE ANALYTICS MARKET FOR GOVERNMENT AGENCIES, BY REGION, 2022–2029 (USD MILLION)          173

TABLE 95           COMMERCIALLY AVAILABLE ANALYTICS SOLUTIONS FOR HEALTHCARE PROVIDERS         174

TABLE 96           HEALTHCARE ANALYTICS MARKET FOR PROVIDERS, BY TYPE,

2022–2029 (USD MILLION)          175

TABLE 97           HEALTHCARE ANALYTICS MARKET FOR PROVIDERS, BY REGION,

2022–2029 (USD MILLION)          175

TABLE 98           COMMERCIALLY AVAILABLE HEALTHCARE ANALYTICS SOLUTIONS

FOR HOSPITALS & CLINICS        176

TABLE 99          HEALTHCARE ANALYTICS MARKET FOR HOSPITALS & CLINICS, BY REGION,

2022–2029 (USD MILLION)          177

TABLE 100         HEALTHCARE ANALYTICS MARKET FOR POST-ACUTE CARE ORGANIZATIONS,

BY REGION, 2022–2029 (USD MILLION)  178

TABLE 101         COMMERCIALLY AVAILABLE HEALTHCARE ANALYTICS SOLUTIONS FOR AMBULATORY SURGERY CENTERS     179

TABLE 102         HEALTHCARE ANALYTICS MARKET FOR AMBULATORY SURGERY CENTERS,

BY REGION, 2022–2029 (USD MILLION)  179

TABLE 103         COMMERCIALLY AVAILABLE SOLUTIONS FOR ACCOUNTABLE CARE ORGANIZATIONS 180

TABLE 104         HEALTHCARE ANALYTICS MARKET FOR OTHER PROVIDERS, BY REGION,

2022–2029 (USD MILLION)          181

TABLE 105         HEALTHCARE ANALYTICS MARKET FOR PHARMACEUTICAL & MEDICAL DEVICE SUPPLY CHAIN, BY TYPE, 2022–2029 (USD MILLION)  182

TABLE 106         HEALTHCARE ANALYTICS MARKET FOR PHARMACEUTICAL & MEDICAL DEVICE SUPPLY CHAIN, BY REGION, 2022–2029 (USD MILLION)              183

TABLE 107         HEALTHCARE ANALYTICS MARKET FOR MANUFACTURERS, BY REGION,

2022–2029 (USD MILLION)          184

TABLE 108         HEALTHCARE ANALYTICS MARKET FOR DISTRIBUTORS & WHOLESALERS,

BY REGION, 2022–2029 (USD MILLION)  185

TABLE 109         HEALTHCARE ANALYTICS MARKET FOR RETAILERS, BY REGION,

2022–2029 (USD MILLION)          186

TABLE 110         HEALTHCARE ANALYTICS MARKET, BY REGION, 2022–2029 (USD MILLION) 188

TABLE 111         NORTH AMERICA: HEALTHCARE ANALYTICS MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          190

TABLE 112         NORTH AMERICA: HEALTHCARE ANALYTICS MARKET, BY COMPONENT,

2022–2029 (USD MILLION)          191

TABLE 113         NORTH AMERICA: HEALTHCARE ANALYTICS SERVICES MARKET, BY TYPE,

2022–2029 (USD MILLION)          191

TABLE 114         NORTH AMERICA: HEALTHCARE ANALYTICS MARKET FOR MANAGED SERVICES,

BY TYPE, 2022–2029 (USD MILLION)       191

TABLE 115         NORTH AMERICA: HEALTHCARE ANALYTICS MARKET FOR PROFESSIONAL SERVICES, BY TYPE, 2022–2029 (USD MILLION) 192

TABLE 116         NORTH AMERICA: HEALTHCARE ANALYTICS SOFTWARE MARKET, BY TYPE,

2022–2029 (USD MILLION)          192

TABLE 117         NORTH AMERICA: HEALTHCARE ANALYTICS MARKET, BY TYPE,

2022–2029 (USD MILLION)          192

TABLE 118         NORTH AMERICA: HEALTHCARE ANALYTICS MARKET, BY APPLICATION,

2022–2029 (USD MILLION)          193

TABLE 119         NORTH AMERICA: FINANCIAL ANALYTICS MARKET, BY TYPE,

2022–2029 (USD MILLION)          193

TABLE 120         NORTH AMERICA: CLINICAL ANALYTICS MARKET, BY TYPE,

2022–2029 (USD MILLION)          194

TABLE 121         NORTH AMERICA: OPERATIONAL & ADMINISTRATIVE ANALYTICS MARKET, BY TYPE, 2022–2029 (USD MILLION)          194

TABLE 122         NORTH AMERICA: HEALTHCARE ANALYTICS MARKET, BY END USER,

2022–2029 (USD MILLION)          195

TABLE 123         NORTH AMERICA: HEALTHCARE ANALYTICS MARKET FOR PAYERS, BY TYPE,

2022–2029 (USD MILLION)          195

TABLE 124         NORTH AMERICA: HEALTHCARE ANALYTICS MARKET FOR PROVIDERS, BY TYPE, 2022–2029 (USD MILLION)            195

TABLE 125         NORTH AMERICA: HEALTHCARE ANALYTICS MARKET FOR PHARMACEUTICAL & MEDICAL DEVICE SUPPLY CHAIN, BY TYPE, 2022–2029 (USD MILLION) 196

TABLE 126         US: HEALTHCARE ANALYTICS MARKET, BY COMPONENT,

2022–2029 (USD MILLION)          197

TABLE 127         US: HEALTHCARE ANALYTICS SERVICES MARKET, BY TYPE,

2022–2029 (USD MILLION)          197

TABLE 128         US: HEALTHCARE ANALYTICS MARKET FOR MANAGED SERVICES, BY TYPE,

2022–2029 (USD MILLION)          198

TABLE 129         US: HEALTHCARE ANALYTICS MARKET FOR PROFESSIONAL SERVICES, BY TYPE, 2022–2029 (USD MILLION)  198

TABLE 130         US: HEALTHCARE ANALYTICS SOFTWARE MARKET, BY TYPE,

2022–2029 (USD MILLION)          198

TABLE 131         US: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2022–2029 (USD MILLION) 199

TABLE 132         US: HEALTHCARE ANALYTICS MARKET, BY APPLICATION,

2022–2029 (USD MILLION)          199

TABLE 133         US: FINANCIAL ANALYTICS MARKET, BY TYPE, 2022–2029 (USD MILLION)          199

TABLE 134         US: CLINICAL ANALYTICS MARKET, BY TYPE, 2022–2029 (USD MILLION)          200

TABLE 135         US: OPERATIONAL & ADMINISTRATIVE ANALYTICS MARKET, BY TYPE,

2022–2029 (USD MILLION)          200

TABLE 136         US: HEALTHCARE ANALYTICS MARKET, BY END USER, 2022–2029 (USD MILLION)     201

TABLE 137         US: HEALTHCARE ANALYTICS MARKET FOR PAYERS, BY TYPE,

2022–2029 (USD MILLION)          201

TABLE 138         US: HEALTHCARE ANALYTICS MARKET FOR PROVIDERS, BY TYPE,

2022–2029 (USD MILLION)          201

TABLE 139         US: HEALTHCARE ANALYTICS MARKET FOR PHARMACEUTICAL & MEDICAL DEVICE SUPPLY CHAIN, BY TYPE, 2022–2029 (USD MILLION) 202

TABLE 140         CANADA: HEALTHCARE ANALYTICS MARKET, BY COMPONENT,

2022–2029 (USD MILLION)          203

TABLE 141         CANADA: HEALTHCARE ANALYTICS SERVICES MARKET, BY TYPE,

2022–2029 (USD MILLION)          203

TABLE 142         CANADA: HEALTHCARE ANALYTICS MARKET FOR MANAGED SERVICES, BY TYPE, 2022–2029 (USD MILLION)  203

TABLE 143         CANADA: HEALTHCARE ANALYTICS MARKET FOR PROFESSIONAL SERVICES,

BY TYPE, 2022–2029 (USD MILLION)       204

TABLE 144         CANADA: HEALTHCARE ANALYTICS SOFTWARE MARKET, BY TYPE,

2022–2029 (USD MILLION)          204

TABLE 145         CANADA: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2022–2029 (USD MILLION)     204

TABLE 146         CANADA: HEALTHCARE ANALYTICS MARKET, BY APPLICATION,

2022–2029 (USD MILLION)          205

TABLE 147         CANADA: FINANCIAL ANALYTICS MARKET, BY TYPE, 2022–2029 (USD MILLION) 205

TABLE 148         CANADA: CLINICAL ANALYTICS MARKET, BY TYPE, 2022–2029 (USD MILLION) 206

TABLE 149         CANADA: OPERATIONAL & ADMINISTRATIVE ANALYTICS MARKET, BY TYPE,

2022–2029 (USD MILLION)          206

TABLE 150         CANADA: HEALTHCARE ANALYTICS MARKET, BY END USER,

2022–2029 (USD MILLION)          206

TABLE 151         CANADA: HEALTHCARE ANALYTICS MARKET FOR PAYERS, BY TYPE,

2022–2029 (USD MILLION)          207

TABLE 152        CANADA: HEALTHCARE ANALYTICS MARKET FOR PROVIDERS, BY TYPE,

2022–2029 (USD MILLION)          207

TABLE 153         CANADA: HEALTHCARE ANALYTICS MARKET FOR PHARMACEUTICAL & MEDICAL DEVICE SUPPLY CHAIN, BY TYPE, 2022–2029 (USD MILLION) 207

TABLE 154         EUROPE: HEALTHCARE ANALYTICS MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          209

TABLE 155         EUROPE: HEALTHCARE ANALYTICS MARKET, BY COMPONENT,

2022–2029 (USD MILLION)          209

TABLE 156         EUROPE: HEALTHCARE ANALYTICS SERVICES MARKET, BY TYPE,

2022–2029 (USD MILLION)          210

TABLE 157         EUROPE: HEALTHCARE ANALYTICS MARKET FOR MANAGED SERVICES,

BY TYPE, 2022–2029 (USD MILLION)       210

TABLE 158         EUROPE: HEALTHCARE ANALYTICS MARKET FOR PROFESSIONAL SERVICES,

BY TYPE, 2022–2029 (USD MILLION)       210

TABLE 159         EUROPE: HEALTHCARE ANALYTICS SOFTWARE MARKET, BY TYPE,

2022–2029 (USD MILLION)          211

TABLE 160         EUROPE: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2022–2029 (USD MILLION)     211

TABLE 161         EUROPE: HEALTHCARE ANALYTICS MARKET, BY APPLICATION,

2022–2029 (USD MILLION)          211

TABLE 162         EUROPE: FINANCIAL ANALYTICS MARKET, BY TYPE, 2022–2029 (USD MILLION) 212

TABLE 163         EUROPE: CLINICAL ANALYTICS MARKET, BY TYPE, 2022–2029 (USD MILLION) 212

TABLE 164         EUROPE: OPERATIONAL & ADMINISTRATIVE ANALYTICS MARKET, BY TYPE,

2022–2029 (USD MILLION)          213

TABLE 165         EUROPE: HEALTHCARE ANALYTICS MARKET, BY END USER,

2022–2029 (USD MILLION)          213

TABLE 166         EUROPE: HEALTHCARE ANALYTICS MARKET FOR PAYERS, BY TYPE,

2022–2029 (USD MILLION)          213

TABLE 167         EUROPE: HEALTHCARE ANALYTICS MARKET FOR PROVIDERS, BY TYPE,

2022–2029 (USD MILLION)          214

TABLE 168         EUROPE: HEALTHCARE ANALYTICS MARKET FOR PHARMACEUTICAL & MEDICAL DEVICE SUPPLY CHAIN, BY TYPE, 2022–2029 (USD MILLION) 214

TABLE 169         GERMANY: HEALTHCARE ANALYTICS MARKET, BY COMPONENT,

2022–2029 (USD MILLION)          215

TABLE 170         GERMANY: HEALTHCARE ANALYTICS SERVICES MARKET, BY TYPE,

2022–2029 (USD MILLION)          215

TABLE 171         GERMANY: HEALTHCARE ANALYTICS MARKET FOR MANAGED SERVICES,

BY TYPE, 2022–2029 (USD MILLION)       216

TABLE 172         GERMANY: HEALTHCARE ANALYTICS MARKET FOR PROFESSIONAL SERVICES,

BY TYPE, 2022–2029 (USD MILLION)       216

TABLE 173         GERMANY: HEALTHCARE ANALYTICS SOFTWARE MARKET, BY TYPE,

2022–2029 (USD MILLION)          216

TABLE 174         GERMANY: HEALTHCARE ANALYTICS MARKET, BY TYPE,

2022–2029 (USD MILLION)          217

TABLE 175         GERMANY: HEALTHCARE ANALYTICS MARKET, BY APPLICATION,

2022–2029 (USD MILLION)          217

TABLE 176         GERMANY: FINANCIAL ANALYTICS MARKET, BY TYPE, 2022–2029 (USD MILLION)     217

TABLE 177         GERMANY: CLINICAL ANALYTICS MARKET, BY TYPE, 2022–2029 (USD MILLION) 218

TABLE 178         GERMANY: OPERATIONAL & ADMINISTRATIVE ANALYTICS MARKET, BY TYPE, 2022–2029 (USD MILLION)    218

TABLE 179         GERMANY: HEALTHCARE ANALYTICS MARKET, BY END USER,

2022–2029 (USD MILLION)          218

TABLE 180         GERMANY: HEALTHCARE ANALYTICS MARKET FOR PAYERS, BY TYPE,

2022–2029 (USD MILLION)          219

TABLE 181         GERMANY: HEALTHCARE ANALYTICS MARKET FOR PROVIDERS, BY TYPE,

2022–2029 (USD MILLION)          219

TABLE 182         GERMANY: HEALTHCARE ANALYTICS MARKET FOR PHARMACEUTICAL & MEDICAL DEVICE SUPPLY CHAIN, BY TYPE, 2022–2029 (USD MILLION) 219

TABLE 183         UK: HEALTHCARE ANALYTICS MARKET, BY COMPONENT,

2022–2029 (USD MILLION)          220

TABLE 184         UK: HEALTHCARE ANALYTICS SERVICES MARKET, BY TYPE,

2022–2029 (USD MILLION)          221

TABLE 185         UK: HEALTHCARE ANALYTICS MARKET FOR MANAGED SERVICES, BY TYPE,

2022–2029 (USD MILLION)          221

TABLE 186         UK: HEALTHCARE ANALYTICS MARKET FOR PROFESSIONAL SERVICES, BY TYPE, 2022–2029 (USD MILLION)  221

TABLE 187         UK: HEALTHCARE ANALYTICS SOFTWARE MARKET, BY TYPE,

2022–2029 (USD MILLION)          222

TABLE 188         UK: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2022–2029 (USD MILLION) 222

TABLE 189         UK: HEALTHCARE ANALYTICS MARKET, BY APPLICATION,

2022–2029 (USD MILLION)          222

TABLE 190         UK: FINANCIAL ANALYTICS MARKET, BY TYPE, 2022–2029 (USD MILLION)          223

TABLE 191         UK: CLINICAL ANALYTICS MARKET, BY TYPE, 2022–2029 (USD MILLION)          223

TABLE 192         UK: OPERATIONAL & ADMINISTRATIVE ANALYTICS MARKET, BY TYPE,

2022–2029 (USD MILLION)          224

TABLE 193         UK: HEALTHCARE ANALYTICS MARKET, BY END USER, 2022–2029 (USD MILLION)     224

TABLE 194         UK: HEALTHCARE ANALYTICS MARKET FOR PAYERS, BY TYPE,

2022–2029 (USD MILLION)          224

TABLE 195         UK: HEALTHCARE ANALYTICS MARKET FOR PROVIDERS, BY TYPE,

2022–2029 (USD MILLION)          225

TABLE 196         UK: HEALTHCARE ANALYTICS MARKET FOR PHARMACEUTICAL & MEDICAL DEVICE SUPPLY CHAIN, BY TYPE, 2022–2029 (USD MILLION) 225

TABLE 197        FRANCE: HEALTHCARE ANALYTICS MARKET, BY COMPONENT,

2022–2029 (USD MILLION)          226

TABLE 198         FRANCE: HEALTHCARE ANALYTICS SERVICES MARKET, BY TYPE,

2022–2029 (USD MILLION)          226

TABLE 199         FRANCE: HEALTHCARE ANALYTICS MARKET FOR MANAGED SERVICES, BY TYPE, 2022–2029 (USD MILLION)  227

TABLE 200         FRANCE: HEALTHCARE ANALYTICS MARKET FOR PROFESSIONAL SERVICES,

BY TYPE, 2022–2029 (USD MILLION)       227

TABLE 201         FRANCE: HEALTHCARE ANALYTICS SOFTWARE MARKET, BY TYPE,

2022–2029 (USD MILLION)          227

TABLE 202         FRANCE: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2022–2029 (USD MILLION)     228

TABLE 203         FRANCE: HEALTHCARE ANALYTICS MARKET, BY APPLICATION,

2022–2029 (USD MILLION)          228

TABLE 204         FRANCE: FINANCIAL ANALYTICS MARKET, BY TYPE, 2022–2029 (USD MILLION) 228

TABLE 205         FRANCE: CLINICAL ANALYTICS MARKET, BY TYPE, 2022–2029 (USD MILLION) 229

TABLE 206         FRANCE: OPERATIONAL & ADMINISTRATIVE ANALYTICS MARKET, BY TYPE,

2022–2029 (USD MILLION)          229

TABLE 207         FRANCE: HEALTHCARE ANALYTICS MARKET, BY END USER,

2022–2029 (USD MILLION)          229

TABLE 208         FRANCE: HEALTHCARE ANALYTICS MARKET FOR PAYERS, BY TYPE,

2022–2029 (USD MILLION)          230

TABLE 209         FRANCE: HEALTHCARE ANALYTICS MARKET FOR PROVIDERS, BY TYPE,

2022–2029 (USD MILLION)          230

TABLE 210         FRANCE: HEALTHCARE ANALYTICS MARKET FOR PHARMACEUTICAL & MEDICAL DEVICE SUPPLY CHAIN, BY TYPE, 2022–2029 (USD MILLION) 230

TABLE 211         ITALY: HEALTHCARE ANALYTICS MARKET, BY COMPONENT,

2022–2029 (USD MILLION)          231

TABLE 212         ITALY: HEALTHCARE ANALYTICS SERVICES MARKET, BY TYPE,

2022–2029 (USD MILLION)          231

TABLE 213         ITALY: HEALTHCARE ANALYTICS MARKET FOR MANAGED SERVICES, BY TYPE, 2022–2029 (USD MILLION)  232

TABLE 214         ITALY: HEALTHCARE ANALYTICS MARKET FOR PROFESSIONAL SERVICES, BY TYPE, 2022–2029 (USD MILLION) 232

TABLE 215         ITALY: HEALTHCARE ANALYTICS SOFTWARE MARKET, BY TYPE,

2022–2029 (USD MILLION)          232

TABLE 216         ITALY: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2022–2029 (USD MILLION) 233

TABLE 217         ITALY: HEALTHCARE ANALYTICS MARKET, BY APPLICATION,

2022–2029 (USD MILLION)          233

TABLE 218         ITALY: FINANCIAL ANALYTICS MARKET, BY TYPE, 2022–2029 (USD MILLION) 233

TABLE 219         ITALY: CLINICAL ANALYTICS MARKET, BY TYPE, 2022–2029 (USD MILLION) 234

TABLE 220         ITALY: OPERATIONAL & ADMINISTRATIVE ANALYTICS MARKET, BY TYPE,

2022–2029 (USD MILLION)          234

TABLE 221         ITALY: HEALTHCARE ANALYTICS MARKET, BY END USER,

2022–2029 (USD MILLION)          234

TABLE 222         ITALY: HEALTHCARE ANALYTICS MARKET FOR PAYERS, BY TYPE,

2022–2029 (USD MILLION)          235

TABLE 223         ITALY: HEALTHCARE ANALYTICS MARKET FOR PROVIDERS, BY TYPE,

2022–2029 (USD MILLION)          235

TABLE 224         ITALY: HEALTHCARE ANALYTICS MARKET FOR PHARMACEUTICAL & MEDICAL DEVICE SUPPLY CHAIN, BY TYPE, 2022–2029 (USD MILLION) 235

TABLE 225         SPAIN: HEALTHCARE ANALYTICS MARKET, BY COMPONENT,

2022–2029 (USD MILLION)          236

TABLE 226         SPAIN: HEALTHCARE ANALYTICS SERVICES MARKET, BY TYPE,

2022–2029 (USD MILLION)          236

TABLE 227         SPAIN: HEALTHCARE ANALYTICS MARKET FOR MANAGED SERVICES, BY TYPE, 2022–2029 (USD MILLION)  237

TABLE 228         SPAIN: HEALTHCARE ANALYTICS MARKET FOR PROFESSIONAL SERVICES, BY TYPE, 2022–2029 (USD MILLION) 237

TABLE 229         SPAIN: HEALTHCARE ANALYTICS SOFTWARE MARKET, BY TYPE,

2022–2029 (USD MILLION)          237

TABLE 230         SPAIN: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2022–2029 (USD MILLION) 238

TABLE 231         SPAIN: HEALTHCARE ANALYTICS MARKET, BY APPLICATION,

2022–2029 (USD MILLION)          238

TABLE 232         SPAIN: FINANCIAL ANALYTICS MARKET, BY TYPE, 2022–2029 (USD MILLION) 238

TABLE 233         SPAIN: CLINICAL ANALYTICS MARKET, BY TYPE, 2022–2029 (USD MILLION) 239

TABLE 234         SPAIN: OPERATIONAL & ADMINISTRATIVE ANALYTICS MARKET, BY TYPE,

2022–2029 (USD MILLION)          239

TABLE 235         SPAIN: HEALTHCARE ANALYTICS MARKET, BY END USER,

2022–2029 (USD MILLION)          239

TABLE 236         SPAIN: HEALTHCARE ANALYTICS MARKET FOR PAYERS, BY TYPE,

2022–2029 (USD MILLION)          240

TABLE 237         SPAIN: HEALTHCARE ANALYTICS MARKET FOR PROVIDERS, BY TYPE,

2022–2029 (USD MILLION)          240

TABLE 238         SPAIN: HEALTHCARE ANALYTICS MARKET FOR PHARMACEUTICAL & MEDICAL DEVICE SUPPLY CHAIN, BY TYPE, 2022–2029 (USD MILLION) 240

TABLE 239         REST OF EUROPE: HEALTHCARE ANALYTICS MARKET, BY COMPONENT,

2022–2029 (USD MILLION)          241

TABLE 240         REST OF EUROPE: HEALTHCARE ANALYTICS SERVICES MARKET, BY TYPE,

2022–2029 (USD MILLION)          241

TABLE 241         REST OF EUROPE: HEALTHCARE ANALYTICS MARKET FOR MANAGED SERVICES,

BY TYPE, 2022–2029 (USD MILLION)       242

TABLE 242         REST OF EUROPE: HEALTHCARE ANALYTICS MARKET FOR PROFESSIONAL SERVICES, BY TYPE, 2022–2029 (USD MILLION) 242

TABLE 243         REST OF EUROPE: HEALTHCARE ANALYTICS SOFTWARE MARKET, BY TYPE,

2022–2029 (USD MILLION)          242

TABLE 244         REST OF EUROPE: HEALTHCARE ANALYTICS MARKET, BY TYPE,

2022–2029 (USD MILLION)          243

TABLE 245         REST OF EUROPE: HEALTHCARE ANALYTICS MARKET, BY APPLICATION,

2022–2029 (USD MILLION)          243

TABLE 246         REST OF EUROPE: FINANCIAL ANALYTICS MARKET, BY TYPE,

2022–2029 (USD MILLION)          243

TABLE 247         REST OF EUROPE: CLINICAL ANALYTICS MARKET, BY TYPE,

2022–2029 (USD MILLION)          244

TABLE 248         REST OF EUROPE: OPERATIONAL & ADMINISTRATIVE ANALYTICS MARKET,

BY TYPE, 2022–2029 (USD MILLION)       244

TABLE 249         REST OF EUROPE: HEALTHCARE ANALYTICS MARKET, BY END USER,

2022–2029 (USD MILLION)          245

TABLE 250         REST OF EUROPE: HEALTHCARE ANALYTICS MARKET FOR PAYERS, BY TYPE, 2022–2029 (USD MILLION)     245

TABLE 251         REST OF EUROPE: HEALTHCARE ANALYTICS MARKET FOR PROVIDERS, BY TYPE, 2022–2029 (USD MILLION)            245

TABLE 252         REST OF EUROPE: HEALTHCARE ANALYTICS MARKET FOR PHARMACEUTICAL & MEDICAL DEVICE SUPPLY CHAIN, BY TYPE, 2022–2029 (USD MILLION) 246

TABLE 253         ASIA PACIFIC: HEALTHCARE ANALYTICS MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          249

TABLE 254         ASIA PACIFIC: HEALTHCARE ANALYTICS MARKET, BY COMPONENT,

2022–2029 (USD MILLION)          249

TABLE 255         ASIA PACIFIC: HEALTHCARE ANALYTICS SERVICES MARKET, BY TYPE,

2022–2029 (USD MILLION)          249

TABLE 256         ASIA PACIFIC: HEALTHCARE ANALYTICS MARKET FOR MANAGED SERVICES,

BY TYPE, 2022–2029 (USD MILLION)       250

TABLE 257         ASIA PACIFIC: HEALTHCARE ANALYTICS MARKET FOR PROFESSIONAL SERVICES, BY TYPE, 2022–2029 (USD MILLION) 250

TABLE 258         ASIA PACIFIC: HEALTHCARE ANALYTICS SOFTWARE MARKET, BY TYPE,

2022–2029 (USD MILLION)          250

TABLE 259         ASIA PACIFIC: HEALTHCARE ANALYTICS MARKET, BY TYPE,

2022–2029 (USD MILLION)          251

TABLE 260         ASIA PACIFIC: HEALTHCARE ANALYTICS MARKET, BY APPLICATION,

2022–2029 (USD MILLION)          251

TABLE 261         ASIA PACIFIC: FINANCIAL ANALYTICS MARKET, BY TYPE,

2022–2029 (USD MILLION)          251

TABLE 262         ASIA PACIFIC: CLINICAL ANALYTICS MARKET, BY TYPE, 2022–2029 (USD MILLION)     252

TABLE 263         ASIA PACIFIC: OPERATIONAL & ADMINISTRATIVE ANALYTICS MARKET, BY TYPE, 2022–2029 (USD MILLION)    252

TABLE 264         ASIA PACIFIC: HEALTHCARE ANALYTICS MARKET, BY END USER,

2022–2029 (USD MILLION)          252

TABLE 265        ASIA PACIFIC: HEALTHCARE ANALYTICS MARKET FOR PAYERS, BY TYPE,

2022–2029 (USD MILLION)          253

TABLE 266         ASIA PACIFIC: HEALTHCARE ANALYTICS MARKET FOR PROVIDERS, BY TYPE,

2022–2029 (USD MILLION)          253

TABLE 267         ASIA PACIFIC: HEALTHCARE ANALYTICS MARKET FOR PHARMACEUTICAL & MEDICAL DEVICE SUPPLY CHAIN, BY TYPE, 2022–2029 (USD MILLION) 253

TABLE 268         JAPAN: HEALTHCARE ANALYTICS MARKET, BY COMPONENT,

2022–2029 (USD MILLION)          254

TABLE 269        JAPAN: HEALTHCARE ANALYTICS SERVICES MARKET, BY TYPE,

2022–2029 (USD MILLION)          254

TABLE 270         JAPAN: HEALTHCARE ANALYTICS MARKET FOR MANAGED SERVICES, BY TYPE, 2022–2029 (USD MILLION)  255

TABLE 271         JAPAN: HEALTHCARE ANALYTICS MARKET FOR PROFESSIONAL SERVICES, BY TYPE, 2022–2029 (USD MILLION) 255

TABLE 272         JAPAN: HEALTHCARE ANALYTICS SOFTWARE MARKET, BY TYPE,

2022–2029 (USD MILLION)          255

TABLE 273         JAPAN: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2022–2029 (USD MILLION) 256

TABLE 274         JAPAN: HEALTHCARE ANALYTICS MARKET, BY APPLICATION,

2022–2029 (USD MILLION)          256

TABLE 275         JAPAN: FINANCIAL ANALYTICS MARKET, BY TYPE, 2022–2029 (USD MILLION) 256

TABLE 276         JAPAN: CLINICAL ANALYTICS MARKET, BY TYPE, 2022–2029 (USD MILLION) 257

TABLE 277         JAPAN: OPERATIONAL & ADMINISTRATIVE ANALYTICS MARKET, BY TYPE,

2022–2029 (USD MILLION)          257

TABLE 278         JAPAN: HEALTHCARE ANALYTICS MARKET, BY END USER,

2022–2029 (USD MILLION)          257

TABLE 279         JAPAN: HEALTHCARE ANALYTICS MARKET FOR PAYERS, BY TYPE,

2022–2029 (USD MILLION)          258

TABLE 280         JAPAN: HEALTHCARE ANALYTICS MARKET FOR PROVIDERS, BY TYPE,

2022–2029 (USD MILLION)          258

TABLE 281         JAPAN: HEALTHCARE ANALYTICS MARKET FOR PHARMACEUTICAL & MEDICAL DEVICE SUPPLY CHAIN, BY TYPE, 2022–2029 (USD MILLION) 258

TABLE 282         CHINA: HEALTHCARE ANALYTICS MARKET, BY COMPONENT,

2022–2029 (USD MILLION)          259

TABLE 283        CHINA: HEALTHCARE ANALYTICS SERVICES MARKET, BY TYPE,

2022–2029 (USD MILLION)          260

TABLE 284         CHINA: HEALTHCARE ANALYTICS MARKET FOR MANAGED SERVICES, BY TYPE, 2022–2029 (USD MILLION)  260

TABLE 285         CHINA: HEALTHCARE ANALYTICS MARKET FOR PROFESSIONAL SERVICES, BY TYPE, 2022–2029 (USD MILLION) 260

TABLE 286         CHINA: HEALTHCARE ANALYTICS SOFTWARE MARKET, BY TYPE,

2022–2029 (USD MILLION)          261

TABLE 287         CHINA: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2022–2029 (USD MILLION)     261

TABLE 288         CHINA: HEALTHCARE ANALYTICS MARKET, BY APPLICATION,

2022–2029 (USD MILLION)          261

TABLE 289         CHINA: FINANCIAL ANALYTICS MARKET, BY TYPE, 2022–2029 (USD MILLION) 262

TABLE 290         CHINA: CLINICAL ANALYTICS MARKET, BY TYPE, 2022–2029 (USD MILLION) 262

TABLE 291         CHINA: OPERATIONAL & ADMINISTRATIVE ANALYTICS MARKET, BY TYPE,

2022–2029 (USD MILLION)          262

TABLE 292         CHINA: HEALTHCARE ANALYTICS MARKET, BY END USER,

2022–2029 (USD MILLION)          263

TABLE 293         CHINA: HEALTHCARE ANALYTICS MARKET FOR PAYERS, BY TYPE,

2022–2029 (USD MILLION)          263

TABLE 294         CHINA: HEALTHCARE ANALYTICS MARKET FOR PROVIDERS, BY TYPE,

2022–2029 (USD MILLION)          263

TABLE 295         CHINA: HEALTHCARE ANALYTICS MARKET FOR PHARMACEUTICAL & MEDICAL DEVICE SUPPLY CHAIN, BY TYPE, 2022–2029 (USD MILLION) 264

TABLE 296         INDIA: HEALTHCARE ANALYTICS MARKET, BY COMPONENT,

2022–2029 (USD MILLION)          265

TABLE 297         INDIA: HEALTHCARE ANALYTICS SERVICES MARKET, BY TYPE,

2022–2029 (USD MILLION)          265

TABLE 298         INDIA: HEALTHCARE ANALYTICS MARKET FOR MANAGED SERVICES, BY TYPE, 2022–2029 (USD MILLION)  265

TABLE 299         INDIA: HEALTHCARE ANALYTICS MARKET FOR PROFESSIONAL SERVICES, BY TYPE, 2022–2029 (USD MILLION) 266

TABLE 300         INDIA: HEALTHCARE ANALYTICS SOFTWARE MARKET, BY TYPE,

2022–2029 (USD MILLION)          266

TABLE 301         INDIA: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2022–2029 (USD MILLION) 266

TABLE 302         INDIA: HEALTHCARE ANALYTICS MARKET, BY APPLICATION,

2022–2029 (USD MILLION)          267

TABLE 303         INDIA: FINANCIAL ANALYTICS MARKET, BY TYPE, 2022–2029 (USD MILLION) 267

TABLE 304         INDIA: CLINICAL ANALYTICS MARKET, BY TYPE, 2022–2029 (USD MILLION) 268

TABLE 305         INDIA: OPERATIONAL & ADMINISTRATIVE ANALYTICS MARKET, BY TYPE,

2022–2029 (USD MILLION)          268

TABLE 306         INDIA: HEALTHCARE ANALYTICS MARKET, BY END USER,

2022–2029 (USD MILLION)          268

TABLE 307         INDIA: HEALTHCARE ANALYTICS MARKET FOR PAYERS, BY TYPE,

2022–2029 (USD MILLION)          269

TABLE 308         INDIA: HEALTHCARE ANALYTICS MARKET FOR PROVIDERS, BY TYPE,

2022–2029 (USD MILLION)          269

TABLE 309         INDIA: HEALTHCARE ANALYTICS MARKET FOR PHARMACEUTICAL & MEDICAL DEVICE SUPPLY CHAIN, BY TYPE, 2022–2029 (USD MILLION) 269

TABLE 310         REST OF ASIA PACIFIC: HEALTHCARE ANALYTICS MARKET, BY COMPONENT,

2022–2029 (USD MILLION)          270

TABLE 311         REST OF ASIA PACIFIC: HEALTHCARE ANALYTICS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)    271

TABLE 312         REST OF ASIA PACIFIC: HEALTHCARE ANALYTICS MARKET FOR MANAGED SERVICES, BY TYPE, 2022–2029 (USD MILLION) 271

TABLE 313         REST OF ASIA PACIFIC: HEALTHCARE ANALYTICS MARKET FOR PROFESSIONAL SERVICES, BY TYPE, 2022–2029 (USD MILLION)       271

TABLE 314         REST OF ASIA PACIFIC: HEALTHCARE ANALYTICS SOFTWARE MARKET, BY TYPE, 2022–2029 (USD MILLION)    272

TABLE 315         REST OF ASIA PACIFIC: HEALTHCARE ANALYTICS MARKET, BY TYPE,

2022–2029 (USD MILLION)          272

TABLE 316         REST OF ASIA PACIFIC: HEALTHCARE ANALYTICS MARKET, BY APPLICATION,

2022–2029 (USD MILLION)          272

TABLE 317         REST OF ASIA PACIFIC: FINANCIAL ANALYTICS MARKET, BY TYPE,

2022–2029 (USD MILLION)          273

TABLE 318         REST OF ASIA PACIFIC: CLINICAL ANALYTICS MARKET, BY TYPE,

2022–2029 (USD MILLION)          273

TABLE 319         REST OF ASIA PACIFIC: OPERATIONAL & ADMINISTRATIVE ANALYTICS MARKET,

BY TYPE, 2022–2029 (USD MILLION)       274

TABLE 320         REST OF ASIA PACIFIC: HEALTHCARE ANALYTICS MARKET, BY END USER,

2022–2029 (USD MILLION)          274

TABLE 321         REST OF ASIA PACIFIC: HEALTHCARE ANALYTICS MARKET FOR PAYERS, BY TYPE, 2022–2029 (USD MILLION)           274

TABLE 322         REST OF ASIA PACIFIC: HEALTHCARE ANALYTICS MARKET FOR PROVIDERS,

BY TYPE, 2022–2029 (USD MILLION)       275

TABLE 323         REST OF ASIA PACIFIC: HEALTHCARE ANALYTICS MARKET FOR PHARMACEUTICAL & MEDICAL DEVICE SUPPLY CHAIN, BY TYPE, 2022–2029 (USD MILLION)     275

TABLE 324         LATIN AMERICA: HEALTHCARE ANALYTICS MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          276

TABLE 325         LATIN AMERICA: HEALTHCARE ANALYTICS MARKET, BY COMPONENT,

2022–2029 (USD MILLION)          277

TABLE 326         LATIN AMERICA: HEALTHCARE ANALYTICS SERVICES MARKET, BY TYPE,

2022–2029 (USD MILLION)          277

TABLE 327         LATIN AMERICA: HEALTHCARE ANALYTICS MARKET FOR MANAGED SERVICES,

BY TYPE, 2022–2029 (USD MILLION)       277

TABLE 328         LATIN AMERICA: HEALTHCARE ANALYTICS MARKET FOR PROFESSIONAL SERVICES, BY TYPE, 2022–2029 (USD MILLION) 278

TABLE 329         LATIN AMERICA: HEALTHCARE ANALYTICS SOFTWARE MARKET, BY TYPE,

2022–2029 (USD MILLION)          278

TABLE 330         LATIN AMERICA: HEALTHCARE ANALYTICS MARKET, BY TYPE,

2022–2029 (USD MILLION)          278

TABLE 331         LATIN AMERICA: HEALTHCARE ANALYTICS MARKET, BY APPLICATION,

2022–2029 (USD MILLION)          279

TABLE 332         LATIN AMERICA: FINANCIAL ANALYTICS MARKET, BY TYPE,

2022–2029 (USD MILLION)          279

TABLE 333         LATIN AMERICA: CLINICAL ANALYTICS MARKET, BY TYPE,

2022–2029 (USD MILLION)          280

TABLE 334         LATIN AMERICA: OPERATIONAL & ADMINISTRATIVE ANALYTICS MARKET, BY TYPE, 2022–2029 (USD MILLION)          280

TABLE 335         LATIN AMERICA: HEALTHCARE ANALYTICS MARKET, BY END USER,

2022–2029 (USD MILLION)          281

TABLE 336         LATIN AMERICA: HEALTHCARE ANALYTICS MARKET FOR PAYERS, BY TYPE,

2022–2029 (USD MILLION)          281

TABLE 337         LATIN AMERICA: HEALTHCARE ANALYTICS MARKET FOR PROVIDERS, BY TYPE, 2022–2029 (USD MILLION)            281

TABLE 338         LATIN AMERICA: HEALTHCARE ANALYTICS MARKET FOR PHARMACEUTICAL & MEDICAL DEVICE SUPPLY CHAIN, BY TYPE, 2022–2029 (USD MILLION) 282

TABLE 339         BRAZIL: HEALTHCARE ANALYTICS MARKET, BY COMPONENT,

2022–2029 (USD MILLION)          283

TABLE 340         BRAZIL: HEALTHCARE ANALYTICS SERVICES MARKET, BY TYPE,

2022–2029 (USD MILLION)          283

TABLE 341         BRAZIL: HEALTHCARE ANALYTICS MARKET FOR MANAGED SERVICES, BY TYPE, 2022–2029 (USD MILLION)  284

TABLE 342         BRAZIL: HEALTHCARE ANALYTICS MARKET FOR PROFESSIONAL SERVICES,

BY TYPE, 2022–2029 (USD MILLION)       284

TABLE 343         BRAZIL: HEALTHCARE ANALYTICS SOFTWARE MARKET, BY TYPE,

2022–2029 (USD MILLION)          284

TABLE 344         BRAZIL: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2022–2029 (USD MILLION)     285

TABLE 345         BRAZIL: HEALTHCARE ANALYTICS MARKET, BY APPLICATION,

2022–2029 (USD MILLION)          285

TABLE 346         BRAZIL: FINANCIAL ANALYTICS MARKET, BY TYPE, 2022–2029 (USD MILLION) 285

TABLE 347         BRAZIL: CLINICAL ANALYTICS MARKET, BY TYPE, 2022–2029 (USD MILLION) 286

TABLE 348         BRAZIL: OPERATIONAL & ADMINISTRATIVE ANALYTICS MARKET, BY TYPE,

2022–2029 (USD MILLION)          286

TABLE 349         BRAZIL: HEALTHCARE ANALYTICS MARKET, BY END USER,

2022–2029 (USD MILLION)          286

TABLE 350         BRAZIL: HEALTHCARE ANALYTICS MARKET FOR PAYERS, BY TYPE,

2022–2029 (USD MILLION)          287

TABLE 351         BRAZIL: HEALTHCARE ANALYTICS MARKET FOR PROVIDERS, BY TYPE,

2022–2029 (USD MILLION)          287

TABLE 352         BRAZIL: HEALTHCARE ANALYTICS MARKET FOR PHARMACEUTICAL & MEDICAL DEVICE SUPPLY CHAIN, BY TYPE, 2022–2029 (USD MILLION) 287

TABLE 353        MEXICO: HEALTHCARE ANALYTICS MARKET, BY COMPONENT,

2022–2029 (USD MILLION)          288

TABLE 354         MEXICO: HEALTHCARE ANALYTICS SERVICES MARKET, BY TYPE,

2022–2029 (USD MILLION)          288

TABLE 355         MEXICO: HEALTHCARE ANALYTICS MARKET FOR MANAGED SERVICES, BY TYPE, 2022–2029 (USD MILLION)  289

TABLE 356         MEXICO: HEALTHCARE ANALYTICS MARKET FOR PROFESSIONAL SERVICES,

BY TYPE, 2022–2029 (USD MILLION)       289

TABLE 357         MEXICO: HEALTHCARE ANALYTICS SOFTWARE MARKET, BY TYPE,

2022–2029 (USD MILLION)          289

TABLE 358         MEXICO: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2022–2029 (USD MILLION)     290

TABLE 359         MEXICO: HEALTHCARE ANALYTICS MARKET, BY APPLICATION,

2022–2029 (USD MILLION)          290

TABLE 360         MEXICO: FINANCIAL ANALYTICS MARKET, BY TYPE, 2022–2029 (USD MILLION) 290

TABLE 361         MEXICO: CLINICAL ANALYTICS MARKET, BY TYPE, 2022–2029 (USD MILLION) 291

TABLE 362         MEXICO: OPERATIONAL & ADMINISTRATIVE ANALYTICS MARKET, BY TYPE,

2022–2029 (USD MILLION)          291

TABLE 363         MEXICO: HEALTHCARE ANALYTICS MARKET, BY END USER,

2022–2029 (USD MILLION)          291

TABLE 364         MEXICO: HEALTHCARE ANALYTICS MARKET FOR PAYERS, BY TYPE,

2022–2029 (USD MILLION)          292

TABLE 365         MEXICO: HEALTHCARE ANALYTICS MARKET FOR PROVIDERS, BY TYPE,

2022–2029 (USD MILLION)          292

TABLE 366         MEXICO: HEALTHCARE ANALYTICS MARKET FOR PHARMACEUTICAL & MEDICAL DEVICE SUPPLY CHAIN, BY TYPE, 2022–2029 (USD MILLION) 292

TABLE 367         REST OF LATIN AMERICA: HEALTHCARE ANALYTICS MARKET, BY COMPONENT, 2022–2029 (USD MILLION)      293

TABLE 368         REST OF LATIN AMERICA: HEALTHCARE ANALYTICS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)    293

TABLE 369         REST OF LATIN AMERICA: HEALTHCARE ANALYTICS MARKET FOR MANAGED SERVICES, BY TYPE, 2022–2029 (USD MILLION) 294

TABLE 370         REST OF LATIN AMERICA: HEALTHCARE ANALYTICS MARKET FOR PROFESSIONAL SERVICES, BY TYPE, 2022–2029 (USD MILLION)       294

TABLE 371         REST OF LATIN AMERICA: HEALTHCARE ANALYTICS SOFTWARE MARKET, BY TYPE, 2022–2029 (USD MILLION)          294

TABLE 372         REST OF LATIN AMERICA: HEALTHCARE ANALYTICS MARKET, BY TYPE,

2022–2029 (USD MILLION)          295

TABLE 373         REST OF LATIN AMERICA: HEALTHCARE ANALYTICS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)     295

TABLE 374         REST OF LATIN AMERICA: FINANCIAL ANALYTICS MARKET, BY TYPE,

2022–2029 (USD MILLION)          296

TABLE 375         REST OF LATIN AMERICA: CLINICAL ANALYTICS MARKET, BY TYPE,

2022–2029 (USD MILLION)          296

TABLE 376         REST OF LATIN AMERICA: OPERATIONAL & ADMINISTRATIVE ANALYTICS MARKET, BY TYPE, 2022–2029 (USD MILLION)          297

TABLE 377         REST OF LATIN AMERICA: HEALTHCARE ANALYTICS MARKET, BY END USER,

2022–2029 (USD MILLION)          297

TABLE 378         REST OF LATIN AMERICA: HEALTHCARE ANALYTICS MARKET FOR PAYERS, BY TYPE, 2022–2029 (USD MILLION)           297

TABLE 379         REST OF LATIN AMERICA: HEALTHCARE ANALYTICS MARKET FOR PROVIDERS,

BY TYPE, 2022–2029 (USD MILLION)       298

TABLE 380         REST OF LATIN AMERICA: HEALTHCARE ANALYTICS MARKET FOR PHARMACEUTICAL & MEDICAL DEVICE SUPPLY CHAIN, BY TYPE,

2022–2029 (USD MILLION)          298

TABLE 381         MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICS MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          299

TABLE 382         MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICS MARKET, BY COMPONENT, 2022–2029 (USD MILLION)      300

TABLE 383         MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)    300

TABLE 384         MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICS MARKET FOR MANAGED SERVICES, BY TYPE, 2022–2029 (USD MILLION) 300

TABLE 385         MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICS MARKET FOR PROFESSIONAL SERVICES, BY TYPE, 2022–2029 (USD MILLION)       301

TABLE 386         MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICS SOFTWARE MARKET, BY TYPE, 2022–2029 (USD MILLION)          301

TABLE 387         MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICS MARKET, BY TYPE,

2022–2029 (USD MILLION)          301

TABLE 388         MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)     302

TABLE 389         MIDDLE EAST & AFRICA: FINANCIAL ANALYTICS MARKET, BY TYPE,

2022–2029 (USD MILLION)          302

TABLE 390         MIDDLE EAST & AFRICA: CLINICAL ANALYTICS MARKET, BY TYPE,

2022–2029 (USD MILLION)          303

TABLE 391         MIDDLE EAST & AFRICA: OPERATIONAL & ADMINISTRATIVE ANALYTICS MARKET, BY TYPE, 2022–2029 (USD MILLION)          303

TABLE 392         MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICS MARKET, BY END USER,

2022–2029 (USD MILLION)          304

TABLE 393         MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICS MARKET FOR PAYERS, BY TYPE, 2022–2029 (USD MILLION)           304

TABLE 394         MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICS MARKET FOR PROVIDERS,

BY TYPE, 2022–2029 (USD MILLION)       304

TABLE 395         MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICS MARKET FOR PHARMACEUTICAL & MEDICAL DEVICE SUPPLY CHAIN, BY TYPE, 2022–2029 (USD MILLION)     305

TABLE 396         GCC COUNTRIES: HEALTHCARE ANALYTICS MARKET, BY COMPONENT,

2022–2029 (USD MILLION)          306

TABLE 397         GCC COUNTRIES: HEALTHCARE ANALYTICS SERVICES MARKET, BY TYPE,

2022–2029 (USD MILLION)          306

TABLE 398         GCC COUNTRIES: HEALTHCARE ANALYTICS MARKET FOR MANAGED SERVICES,

BY TYPE, 2022–2029 (USD MILLION)       306

TABLE 399         GCC COUNTRIES: HEALTHCARE ANALYTICS MARKET FOR PROFESSIONAL SERVICES, BY TYPE, 2022–2029 (USD MILLION) 307

TABLE 400         GCC COUNTRIES: HEALTHCARE ANALYTICS SOFTWARE MARKET, BY TYPE,

2022–2029 (USD MILLION)          307

TABLE 401         GCC COUNTRIES: HEALTHCARE ANALYTICS MARKET, BY TYPE,

2022–2029 (USD MILLION)          307

TABLE 402         GCC COUNTRIES: HEALTHCARE ANALYTICS MARKET, BY APPLICATION,

2022–2029 (USD MILLION)          308

TABLE 403         GCC COUNTRIES: FINANCIAL ANALYTICS MARKET, BY TYPE,

2022–2029 (USD MILLION)          308

TABLE 404         GCC COUNTRIES: CLINICAL ANALYTICS MARKET, BY TYPE,

2022–2029 (USD MILLION)          309

TABLE 405         GCC COUNTRIES: OPERATIONAL & ADMINISTRATIVE ANALYTICS MARKET, BY TYPE, 2022–2029 (USD MILLION)          309

TABLE 406         GCC COUNTRIES: HEALTHCARE ANALYTICS MARKET, BY END USER,

2022–2029 (USD MILLION)          310

TABLE 407         GCC COUNTRIES: HEALTHCARE ANALYTICS MARKET FOR PAYERS, BY TYPE,

2022–2029 (USD MILLION)          310

TABLE 408         GCC COUNTRIES: HEALTHCARE ANALYTICS MARKET FOR PROVIDERS, BY TYPE, 2022–2029 (USD MILLION)            310

TABLE 409         GCC COUNTRIES: HEALTHCARE ANALYTICS MARKET FOR PHARMACEUTICAL & MEDICAL DEVICE SUPPLY CHAIN, BY TYPE, 2022–2029 (USD MILLION) 311

TABLE 410         REST OF MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICS MARKET,

BY COMPONENT, 2022–2029 (USD MILLION)      311

TABLE 411         REST OF MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICS SERVICES MARKET,

BY TYPE, 2022–2029 (USD MILLION)       312

TABLE 412         REST OF MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICS MARKET FOR MANAGED SERVICES, BY TYPE, 2022–2029 (USD MILLION)              312

TABLE 413         REST OF MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICS MARKET FOR PROFESSIONAL SERVICES, BY TYPE, 2022–2029 (USD MILLION)              312

TABLE 414         REST OF MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICS SOFTWARE MARKET, BY TYPE, 2022–2029 (USD MILLION)          313

TABLE 415         REST OF MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2022–2029 (USD MILLION)    313

TABLE 416         REST OF MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICS MARKET,

BY APPLICATION, 2022–2029 (USD MILLION)     313

TABLE 417         REST OF MIDDLE EAST & AFRICA: FINANCIAL ANALYTICS MARKET, BY TYPE,

2022–2029 (USD MILLION)          314

TABLE 418         REST OF MIDDLE EAST & AFRICA: CLINICAL ANALYTICS MARKET, BY TYPE,

2022–2029 (USD MILLION)          314

TABLE 419         REST OF MIDDLE EAST & AFRICA: OPERATIONAL & ADMINISTRATIVE ANALYTICS MARKET, BY TYPE, 2022–2029 (USD MILLION)              315

TABLE 420         REST OF MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICS MARKET,

BY END USER, 2022–2029 (USD MILLION)            315

TABLE 421         REST OF MIDDLE EAST & AFRICA HEALTHCARE ANALYTICS MARKET FOR PAYERS, BY TYPE, 2022–2029 (USD MILLION)         315

TABLE 422         REST OF MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICS MARKET FOR PROVIDERS, BY TYPE, 2022–2029 (USD MILLION) 316

TABLE 423         REST OF MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICS MARKET FOR PHARMACEUTICAL & MEDICAL DEVICE SUPPLY CHAIN, BY TYPE,

2022–2029 (USD MILLION)          316

TABLE 424         OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN HEALTHCARE

ANALYTICS MARKET, 2021–2024 318

TABLE 425         HEALTHCARE ANALYTICS MARKET: DEGREE OF COMPETITION 320

TABLE 426         HEALTHCARE ANALYTICS MARKET: REGION FOOTPRINT              327

TABLE 427         HEALTHCARE ANALYTICS MARKET: COMPONENT FOOTPRINT      328

TABLE 428         HEALTHCARE ANALYTICS MARKET: APPLICATION FOOTPRINT      329

TABLE 429         HEALTHCARE ANALYTICS MARKET: END-USER FOOTPRINT              330

TABLE 430         HEALTHCARE ANALYTICS MARKET: KEY STARTUPS/SMES              333

TABLE 431         HEALTHCARE ANALYTICS MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SMES  334

TABLE 432         HEALTHCARE ANALYTICS MARKET: PRODUCT/SOLUTION LAUNCHES/ENHANCEMENTS/APPROVALS/UPGRADES,

JANUARY 2021–OCTOBER 2024  335

TABLE 433         HEALTHCARE ANALYTICS MARKET: DEALS, JANUARY 2021–OCTOBER 2024 336

TABLE 434         HEALTHCARE ANALYTICS MARKET: EXPANSIONS, JANUARY 2021–OCTOBER 2024     337

TABLE 435         MERATIVE: COMPANY OVERVIEW         338

TABLE 436         MERATIVE: PRODUCTS/SOLUTIONS/SERVICES OFFERED              339

TABLE 437         MERATIVE: PRODUCT/SOLUTION LAUNCHES/ENHANCEMENTS/APPROVALS/UPGRADES,

JANUARY 2021–OCTOBER 2024  339

TABLE 438         MERATIVE: DEALS, JANUARY 2021–OCTOBER 2024         340

TABLE 439         SAS INSTITUTE INC.: COMPANY OVERVIEW      341

TABLE 440         SAS INSTITUTE INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED          341

TABLE 441         SAS INSTITUTE INC.: PRODUCT/SOLUTION LAUNCHES/ENHANCEMENTS/APPROVALS/UPGRADES,

JANUARY 2021–OCTOBER 2024  342

TABLE 442         OPTUM, INC.: COMPANY OVERVIEW     344

TABLE 443         OPTUM, INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED              345

TABLE 444         OPTUM, INC.: DEALS, JANUARY 2021–OCTOBER 2024     346

TABLE 445         ORACLE: COMPANY OVERVIEW             348

TABLE 446         ORACLE: PRODUCTS/SOLUTIONS/SERVICES OFFERED 349

TABLE 447         ORACLE: PRODUCT/SOLUTION LAUNCHES/ENHANCEMENTS/APPROVALS/UPGRADES,

JANUARY 2021–OCTOBER 2024  350

TABLE 448         ORACLE: DEALS, JANUARY 2021–OCTOBER 2024 351

TABLE 449         ORACLE: EXPANSIONS, JANUARY 2021–OCTOBER 2024  352

TABLE 450         VERADIGM LLC: COMPANY OVERVIEW 353

TABLE 451         VERADIGM LLC: PRODUCTS/SOLUTIONS/SERVICES OFFERED              354

TABLE 452         VERADIGM LLC: PRODUCT/SOLUTION LAUNCHES/ENHANCEMENTS/APPROVALS/ UPGRADES, JANUARY 2021–OCTOBER 2024 355

TABLE 453         VERADIGM LLC: DEALS, JANUARY 2021–OCTOBER 2024 355

TABLE 454         VERADIGM LLC: EXPANSIONS, JANUARY 2021–OCTOBER 2024              357

TABLE 455         VERADIGM LLC: OTHER DEVELOPMENTS, JANUARY 2021–OCTOBER 2024 357

TABLE 456         EXLSERVICE HOLDINGS, INC.: COMPANY OVERVIEW    359

TABLE 457         EXLSERVICE HOLDINGS, INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED   360

TABLE 458         EXLSERVICE HOLDINGS, INC.: PRODUCT SOLUTION LAUNCHES/ENHANCEMENTS/ APPROVALS/UPGRADES, JANUARY 2021–OCTOBER 2024 361

TABLE 459         EXLSERVICE HOLDINGS, INC.: DEALS, JANUARY 2021–OCTOBER 2024 361

TABLE 460         EXLSERVICE HOLDINGS, INC.: OTHER DEVELOPMENTS,

JANUARY 2021–OCTOBER 2024  362

TABLE 461         CITIUSTECH INC.: COMPANY OVERVIEW           363

TABLE 462         CITIUSTECH INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED          363

TABLE 463         CITIUSTECH INC.: PRODUCT/SOLUTION LAUNCHES/ENHANCEMENTS/APPROVALS/ UPGRADES, JANUARY 2021–OCTOBER 2024 364

TABLE 464         CITIUSTECH INC.: DEALS, JANUARY 2021–OCTOBER 2024              365

TABLE 465         CITIUSTECH INC.: OTHER DEVELOPMENTS, JANUARY 2021–OCTOBER 2024 365

TABLE 466         CITIUSTECH INC.: OTHER DEVELOPMENTS, JANUARY 2021–OCTOBER 2024 365

TABLE 467         HEALTH CATALYST: COMPANY OVERVIEW       366

TABLE 468         HEALTH CATALYST: PRODUCTS/SOLUTIONS/SERVICES OFFERED          367

TABLE 469         HEALTH CATALYST: PRODUCT SOLUTION LAUNCHES/ENHANCEMENTS/APPROVALS/ UPGRADES,

JANUARY 2021–OCTOBER 2024  368

TABLE 470         HEALTH CATALYST: DEALS, JANUARY 2021–OCTOBER 2024              368

TABLE 471         CVS HEALTH: COMPANY OVERVIEW     370

TABLE 472         CVS HEALTH: PRODUCTS/SOLUTIONS/SERVICES OFFERED              371

TABLE 473         CVS HEALTH: DEALS, JANUARY 2021–OCTOBER 2024     372

TABLE 474         INOVALON: COMPANY OVERVIEW        373

TABLE 475         INOVALON: PRODUCTS/SOLUTIONS/SERVICES OFFERED              373

TABLE 476         INOVALON: PRODUCT/SOLUTION LAUNCHES/ENHANCEMENTS/APPROVALS/UPGRADES,

JANUARY 2021–OCTOBER 2024  374

TABLE 477         INOVALON: DEALS, JANUARY 2021–OCTOBER 2024        375

TABLE 478         INOVALON: EXPANSIONS, JANUARY 2021–OCTOBER 2024              375

TABLE 479         INOVALON: OTHER DEVELOPMENTS, JANUARY 2021–OCTOBER 2024 375

TABLE 480         MCKESSON CORPORATION: COMPANY OVERVIEW       376

TABLE 481         MCKESSON CORPORATION: PRODUCTS/SOLUTIONS/SERVICES OFFERED   377

TABLE 482         MCKESSON CORPORATION: DEALS, JANUARY 2021–OCTOBER 2024      378

TABLE 483         MEDEANALYTICS, INC.: COMPANY OVERVIEW 379

TABLE 484         MEDEANALYTICS, INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED          379

TABLE 485         MEDEANALYTICS, INC.: DEALS, JANUARY 2021–OCTOBER 2024              380

TABLE 486         MEDEANALYTICS, INC.: OTHER DEVELOPMENTS, JANUARY 2021–OCTOBER 2024     380

TABLE 487         COTIVITI, INC.: COMPANY OVERVIEW  381

TABLE 488         COTIVITI, INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED              381

TABLE 489         COTIVITI, INC.: PRODUCT/SOLUTION LAUNCHES/ENHANCEMENTS/APPROVALS/ UPGRADES, JANUARY 2021–OCTOBER 2024 382

TABLE 490         COTIVITI, INC.: OTHER DEVELOPMENTS, JANUARY 2021–OCTOBER 2024 382

TABLE 491         APIXIO, INC.: COMPANY OVERVIEW      383

TABLE 492         APIXIO, INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED              383

TABLE 493         APIXIO, INC.: PRODUCT/SOLUTION LAUNCHES/ENHANCEMENTS/APPROVALS/UPGRADES,

JANUARY 2021–OCTOBER 2024  384

TABLE 494         APIXIO, INC.: DEALS, JANUARY 2021–OCTOBER 2024      385

TABLE 495         ENLITIC: COMPANY OVERVIEW             386

TABLE 496         ENLITIC: PRODUCTS/SOLUTIONS/SERVICES OFFERED 386

TABLE 497         ENLITIC: PRODUCT/SOLUTION LAUNCHES/ENHANCEMENTS/APPROVALS/UPGRADES,

JANUARY 2021–OCTOBER 2024  387

TABLE 498         ENLITIC: DEALS, JANUARY 2021–OCTOBER 2024 388

TABLE 499         KOMODO HEALTH, INC.: COMPANY OVERVIEW             389

TABLE 500         KOMODO HEALTH, INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED          389

TABLE 501         KOMODO HEALTH, INC.: PRODUCT/SOLUTION LAUNCHES/ENHANCEMENTS/APPROVALS/UPGRADES,

JANUARY 2021–OCTOBER 2024  390

TABLE 502         KOMODO HEALTH, INC.: DEALS, JANUARY 2021–OCTOBER 2024      390

TABLE 503         HEALTHEC, LLC: COMPANY OVERVIEW             392

TABLE 504         HEALTHEC, LLC: PRODUCTS/SOLUTIONS/SERVICES OFFERED              392

TABLE 505         HEALTHEC, LLC: DEALS, JANUARY 2021–OCTOBER 2024              392

TABLE 506         IQVIA: COMPANY OVERVIEW    393

TABLE 507         IQVIA: PRODUCTS/SOLUTIONS/SERVICES OFFERED     394

TABLE 508         IQVIA: DEALS, JANUARY 2021–OCTOBER 2024    395

TABLE 509         WIPRO: COMPANY OVERVIEW  396

TABLE 510         WIPRO: PRODUCTS/SOLUTIONS/SERVICES OFFERED   398

TABLE 511         ARCADIA SOLUTIONS, LLC.: COMPANY OVERVIEW       399

TABLE 512         EVIDATION HEALTH, INC.: COMPANY OVERVIEW          399

TABLE 513         HEALTHCORUM: COMPANY OVERVIEW             400

TABLE 514         AETION, INC.: COMPANY OVERVIEW    400

TABLE 515         TREDENCE.INC.: COMPANY OVERVIEW 401

TABLE 516         SISENSE LTD.: COMPANY OVERVIEW    401

LIST OF FIGURES

FIGURE 1           HEALTHCARE ANALYTICS MARKET SEGMENTATION AND REGIONAL SCOPE         39

FIGURE 2           HEALTHCARE ANALYTICS MARKET: RESEARCH DESIGN              42

FIGURE 3           PRIMARY SOURCES       45

FIGURE 4           BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS 46

FIGURE 5           BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION,

AND REGION    47

FIGURE 6           RESEARCH METHODOLOGY: HYPOTHESIS BUILDING  48

FIGURE 7           SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS          49

FIGURE 8           REVENUE SHARE ANALYSIS ILLUSTRATION OF OPTUM, INC. (2023)   49

FIGURE 9           CAGR PROJECTIONS FROM ANALYSIS OF MARKET DYNAMICS, 2024–2029          51

FIGURE 10         CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS   52

FIGURE 11         MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH       52

FIGURE 12         HEALTHCARE ANALYTICS MARKET: DATA TRIANGULATION METHODOLOGY           54

FIGURE 13         HEALTHCARE ANALYTICS MARKET, BY TYPE, 2024 VS. 2029 (USD MILLION) 57

FIGURE 14         HEALTHCARE ANALYTICS MARKET, BY APPLICATION, 2024 VS. 2029 (USD MILLION)     58

FIGURE 15         HEALTHCARE ANALYTICS MARKET, BY COMPONENT, 2024 VS. 2029 (USD MILLION)     58

FIGURE 16         HEALTHCARE ANALYTICS MARKET, BY END USER, 2024 VS. 2029 (USD MILLION)     59

FIGURE 17         GEOGRAPHICAL SNAPSHOT OF HEALTHCARE ANALYTICS MARKET            60

FIGURE 18         GOVERNMENT INITIATIVES TO INCREASE ELECTRONIC HEALTH RECORD ADOPTION AND INCREASED PRESSURE TO CURB HEALTHCARE COSTS TO PROPEL MARKET       61

FIGURE 19         NORTH AMERICA HELD LARGEST SHARE OF HEALTHCARE ANALYTICS MARKET

IN 2023 62

FIGURE 20         INDIA TO WITNESS HIGHEST GROWTH DURING FORECAST PERIOD              63

FIGURE 21         NORTH AMERICA DOMINATED MARKET IN 2023            63

FIGURE 22         INDIA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD       64

FIGURE 23         HEALTHCARE ANALYTICS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES,

AND CHALLENGES        65

FIGURE 24         HEALTH EXPENDITURE AS A SHARE OF GDP, 2022 (OR NEAREST YEAR)             68

FIGURE 25         HEALTHCARE SECURITY BREACHES OF 500 + RECORDS, 2009–2023      71

FIGURE 26         INDIVIDUALS AFFECTED BY HEALTHCARE SECURITY BREACHES, 2009–2023   72

FIGURE 27         REVENUE SHIFT AND NEW REVENUE POCKETS FOR PLAYERS IN

HEALTHCARE ANALYTICS MARKET      77

FIGURE 28         HEALTHCARE ANALYTICS MARKET: ECOSYSTEM ANALYSIS              81

FIGURE 29         HEALTHCARE ANALYTICS MARKET: VALUE CHAIN ANALYSIS              82

FIGURE 30         HEALTHCARE ANALYTICS MARKET: PORTER’S FIVE FORCES ANALYSIS          94

FIGURE 31         HEALTHCARE ANALYTICS MARKET: PATENT ANALYSIS,

JANUARY 2015–SEPTEMBER 2024            97

FIGURE 32         INFLUENCE OF STAKEHOLDERS IN BUYING PROCESS FOR END USER         99

FIGURE 33         KEY BUYING CRITERIA FOR END USER  100

FIGURE 35         MARKET POTENTIAL OF AI/GEN AI IN ENHANCING HEALTHCARE ANALYTICS ACROSS INDUSTRIES             109

FIGURE 36         IMPACT OF AI/GEN AI ON INTERCONNECTED AND ADJACENT ECOSYSTEMS   111

FIGURE 37         NORTH AMERICA: HEALTHCARE ANALYTICS MARKET SNAPSHOT        190

FIGURE 38         ASIA PACIFIC: HEALTHCARE ANALYTICS MARKET SNAPSHOT              248

FIGURE 39         HEALTHCARE ANALYTICS MARKET: REVENUE ANALYSIS OF KEY PLAYERS,

2019–2023          319

FIGURE 40        HEALTHCARE ANALYTICS MARKET: MARKET SHARE ANALYSIS, 2023      320

FIGURE 41         EV/EBITDA OF KEY VENDORS, 2024       322

FIGURE 42         YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF HEALTHCARE ANALYTICS VENDORS, 2024       322

FIGURE 43         HEALTHCARE ANALYTICS MARKET: BRAND/SOFTWARE COMPARISON   323

FIGURE 44         HEALTHCARE ANALYTICS MARKET: COMPANY EVALUATION MATRIX

(KEY PLAYERS), 2023     325

FIGURE 45         HEALTHCARE ANALYTICS MARKET: COMPANY FOOTPRINT              326

FIGURE 46         HEALTHCARE ANALYTICS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023           332

FIGURE 47         OPTUM, INC: COMPANY SNAPSHOT (2023)        344

FIGURE 48         ORACLE: COMPANY SNAPSHOT (2023) 349

FIGURE 49         VERADIGM LLC: COMPANY SNAPSHOT (2021)  354

FIGURE 50         EXLSERVICE HOLDINGS, INC.: COMPANY SNAPSHOT (2023)              360

FIGURE 51         HEALTH CATALYST: COMPANY SNAPSHOT (2023)         366

FIGURE 52         CVS HEALTH: COMPANY SNAPSHOT (2021)       371

FIGURE 53         MCKESSON CORPORATION: COMPANY SNAPSHOT (2023)              377

FIGURE 54         IQVIA: COMPANY SNAPSHOT (2023)      394

FIGURE 55         WIPRO: COMPANY SNAPSHOT (2023)    397

MarketsandMarkets（マーケッツアンドマーケッツ）は広範な市場を対象にした市場調査レポートを出版しています。世界中の企業に高い評価を得ており、著名メディアでの引用頻度も高い、インドの最大手級の市場調査会社です。

ライセンス別価格表

調査会社の事情により予告なしに変更されることがございます。最新の状況およびその他のパターンについてはお問い合わせください。

ライセンスタイプ1

ライセンスタイプ2

ライセンスタイプ3

ミニレポート　※定性調査にフォーカスした調査レポートです。詳細はお問合せください。

ご購入に関するご案内

価格・納期について

• 価格
  • ウェブサイトに記載の外貨（定価）を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。見積金額はレート変動に関係なく見積書発行日より2週間有効です。手数料（ハンドリングチャージ）無料。
• ライセンス
  • シングルユーザライセンス
    • 1名のみレポートファイルのご利用が可能です。
  • マルチユーザライセンス
    • 同一企業内（関連会社除く）5名までレポートファイルのご利用が可能です。
  • コーポレートライセンス
    • 同一企業および100％持株会社間・人数無制限でレポートファイルのご利用が可能です。
  • エンタープライズサイトライセンス
    • 特別ライセンスです。適用範囲についてはお問合せください。
• 納品形態
  • Eメール
• 納期
  • ご注文後2営業日以内

ご注文方法

• レポートページ内のお問い合わせフォームより見積もりをご請求ください。確認次第見積書と発注書をお送りいたします。既に弊社の見積書をお持ちの場合にはEメールまたはFAXでご注文ください。

その他

• 商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。

株式会社SEMABIZはMarketsandMarketsの日本に拠点をおく販売代理店として、MarketsandMarketsのレポートを販売しております。サンプルページのご依頼、見積り、レポートに関するご質問など購入前のご相談はいつでもお気軽にご連絡ください。

割引可能なレポートが多数ございます。価格・サンプルについてはお気軽にご相談ください。

最新調査レポート

• 沈降シリカ市場 – 2030年までの世界予測 2025-03-07
• スマートメーター市場 – 2030年までの世界予測 2025-03-07
• 産業用計測市場 – 2030年までの世界予測 2025-03-06
• 精密ろ過膜市場- 2029年までの世界予測 2025-03-06
• グリーンテクノロジーと持続可能性市場 – 2030年までの世界予測 2025-03-06

MarketsandMarkets  出版レポート一覧